ASSET PURCHASE AGREEMENT

Exhibit 1A-6B

 

 

ASSET PURCHASE AGREEMENT

 

This Asset Purchase Agreement (this “Agreement”), dated as of December 9, 2014 (the “Effective Date”), is made by and among Harbor Therapeutics, Inc., a Delaware corporation (“Seller”), Harbor Diversified, Inc., a Delaware corporation (“Parent”), and Reserva, LLC (“Buyer”). Buyer, Parent and Seller may be referred to herein each individually as a “Party” and collectively as the “Parties”.

 

RECITALS

 

WHEREAS, Buyer desires to purchase and assume from Seller and Seller desires to sell and assign to Buyer the Acquired Assets and the Assumed Liabilities on the terms and conditions set forth herein; and

 

WHEREAS, Seller is the wholly-owned subsidiary of Parent and Parent owns 100% of the issued and outstanding shares of capital stock of Seller.

 

NOW, THEREFORE, in consideration of the mutual benefits to be derived from this Agreement and of the representations, warranties, conditions, agreements and promises contained herein and other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the Parties hereto, intending to be legally bound, hereby agree as follows:

 

ARTICLE I     
DEFINITIONS; INTERPRETATION

 

Section 1.1.     Definitions. The capitalized terms used in this Agreement have the respective meanings ascribed to them as follows:

 

“Acquired Assets” has the meaning set forth in Section 2.2(a).

 

“Action” means any claim, action, suit, arbitration, inquiry, audit, proceeding or investigation by or before or otherwise involving, any Governmental Authority.

 

“Affiliate” means, with respect to any Person, any other Person directly or indirectly controlling or controlled by, or under direct or indirect common control with, such first Person. For purposes of this definition, a Person shall be deemed, in any event, to control another Person if it (a) owns or controls, directly or indirectly, or has the ability to direct or cause the direction or control of, more than 50% of the voting equity of the other Person, or (b) has the ability to direct, cause the direction of, or control the actions of such other Person, whether through direct or indirect ownership of voting equity, by contract or otherwise.

 

“Agreement” has the meaning set forth in the preamble hereof.

 

“Applicable Law” means any applicable supra-national, federal, state, regional, local or foreign constitution, treaty, law, statute, ordinance, rule, regulation, interpretation, directive, policy, administrative code, guidance, order, writ, award, decree, injunction, judgment, stay or restraining order of any Governmental Authority, the terms of any Permit, and any other ruling or decision of, agreement with or by, or any other requirement of, any Governmental Authority.

 

 
 
 

 

“Assumed Contracts” means the CIPI Agreements and all other Contracts that solely relate to the Purchased Intellectual Property.

 

“Assumed Liabilities” has the meaning set forth in Section 2.3(a).

 

“Business Day” means any day excluding Saturdays, Sundays and any day that is a legal holiday under the laws of the United States or that is a day on which banking institutions located in New York City, New York are authorized or required by Applicable Law or other governmental action to close.

 

“Buyer” has the meaning set forth in the preamble hereof.

 

“Buyer Recipient” has the meaning set forth in the definition of Seller Confidential Information.

 

“CIPI Agreements” means those certain License Agreements, related to HE2000, HE3235, and HE3286, respectively, each effective December 22, 2010 between Seller (as assignee of Harbor Biosciences, Inc.) and China Institute of Pharmaceutical Industry (“CIPI”), and that certain Non-Exclusive Distribution Agreement effective December 22, 2010 between Seller (as assignee of Harbor Biosciences, Inc.) and CIPI.

 

“Code” means the Internal Revenue Code of 1986, as amended.

 

“Contracts” shall mean contracts, leases, indentures, agreements, commitments, purchase orders and all other legally binding arrangements, whether in existence on the date hereof or subsequently entered into, including all amendments thereto.

 

“Control” including its various tenses and derivatives (such as “Controlled” and “Controlling”) means (a) when used with respect to any Person, the possession, directly or indirectly, of the power to direct or cause the direction of the management and policies of such entity, whether through the ownership of voting securities, by contract or otherwise, (b) when used with respect to any security, the possession, directly or indirectly, of the power to vote, or to direct the voting of, such security or the power to dispose of, or to direct the disposition of, such security, and (c) when used with respect to any Intellectual Property, possession of the right, whether directly or indirectly, and whether by ownership, license or otherwise, to Exploit, assign or grant a license, sublicense or other right to or under such Intellectual Property.

 

“Effective Date” has the meaning set forth in the preamble hereto.

 

“Excluded Liabilities” has the meaning set forth in Section 2.3(c).

 

“Exploit” or “Exploitation” means to make, have made, import, use, sell, offer for sale, or otherwise dispose of, including all discovery, research, development, registration, modification, enhancement, improvement, manufacture, storage, formulation, optimization, importation, exportation, transportation, distribution, commercialization, promotion and marketing activities related thereto.

 

“Governmental Authority” means any supra-national, federal, state, local or foreign government, legislature, governmental or administrative agency, department, commission, bureau, board, instrumentality, self-regulatory association or authority, court or other authority of tribunal of competent jurisdiction (including any arbitration or other alternative dispute forum), or any other governmental authority or instrumentality anywhere in the world.

 

 
2
 

 

“Intellectual Property” means (a) all inventions (whether patentable or unpatentable and whether or not reduced to practice), all improvements thereto, and all patents, patent applications, and patent disclosures, together with all reissuances, continuations, continuations-in-part, revisions, extensions, and reexaminations thereof, (b) all trademarks, service marks, trade dress, logos, trade names, and corporate names, together with all translations, adaptations, derivations, and combinations thereof and including all goodwill associated therewith, and all applications, registrations, and renewals in connection therewith, (c) all copyrightable works, all copyrights, and all applications, registrations, and renewals in connection therewith, (d) all trade secrets, confidential business information and know how, (e) all other proprietary rights, and (f) licenses granting any rights with respect to any of the foregoing.

 

“Key Assets” has the meaning set forth in Section 3.5.

 

“Lien” means any lien (statutory or otherwise), security interest, pledge, hypothecation, or mortgage.

 

“Order” means any writ, judgment, decree, injunction or similar order, including consent orders, of any Governmental Authority (in each such case whether preliminary or final).

 

“Parent” has the meaning set forth in the preamble hereof.

 

“Party” or “Parties” has the meaning set forth in the preamble hereto.

 

“Patents” means (i) all issued, reissued or reexamined patents, revivals of patents, utility models, certificates of invention, registrations of patents and extensions thereof, regardless of country or formal name, issued by the United States Patent and Trademark Office and any other applicable Governmental Authority, and (ii) all published or unpublished non-provisional and provisional patent applications, and reexamination proceedings.

 

“Permits” means licenses, permits, approvals, concessions, certificates, consents, qualifications, registrations, privileges and other authorizations and rights, including Regulatory Approvals, from or issued by any Governmental Authority, together with any renewals, extensions, or modifications thereof and any additions thereto.

 

“Person” means a human being, labor organization, partnership, firm, enterprise, association, joint venture, corporation, limited liability company, cooperative, legal representative, foundation, society, political party, estate, trust, trustee, trustee in bankruptcy, receiver or any other organization or entity whatsoever, including any Governmental Authority.

 

“Purchased Intellectual Property” means all Intellectual Property in Seller’s possession and Control to the extent related to hormone-related sterols for treating medical conditions.

 

“Related Documents” means, other than this Agreement, all agreements, certificates and documents signed and delivered by any Party in connection with this Agreement.

 

“Representatives” has the meaning set forth in Section 5.1(a).

 

 
3
 

 

“Seller” has the meaning set forth in the preamble hereof.

 

“Seller Confidential Information” means (a) all financial, technical, commercial, proprietary or other information of Seller, an Affiliate of Seller disclosed by Seller or an Affiliate of Seller to Buyer, its Affiliates or any of its or their officers, directors, employees (or Representatives for purposes of this definition, each a “Buyer Recipient”) in connection with the transactions contemplated by this Agreement that does not relate to the Acquired Assets, (b) each of the provisions contained in this Agreement and the Related Documents, (c) all financial, technical, commercial, proprietary or other information of Seller or an Affiliate of Seller disclosed by Seller or an Affiliate of Seller to any Governmental Authority in connection with any filings or review in connection with the transactions contemplated hereunder not relating to the Acquired Assets; and (d) any third-party confidential information included with, or incorporated in, any information provided by Seller or an Affiliate of Seller to a Buyer Recipient. Notwithstanding the preceding sentence, the definition of Seller Confidential Information does not include any information that (i) is in the public domain at the time of disclosure to a Buyer Recipient or becomes part of the public domain after such disclosure through no fault of such Buyer Recipient, (ii) is already in the possession of a Buyer Recipient at the time of disclosure to such Buyer Recipient and had not been previously provided by Seller or its Affiliates, (iii) is disclosed to a Buyer Recipient by any Person other than by or on behalf of Seller or its Affliates, or their Representatives; provided that, no Buyer Recipient has actual knowledge that such Person is prohibited from disclosing such information (either by reason of contract or legal or fiduciary obligation) or (iv) is developed independently by a Buyer Recipient without the use of any Seller Confidential Information.

 

“Seller Materials” means any and all clinical drug supply, active pharmaceutical ingredient, samples for stability and clinical samples owned by Seller or its Affiliates located at EMINENT Services Corporation and set forth on Schedule A.

 

“Seller Patent Rights” means the Patents listed on Schedule B, and any future Patents that claim priority from or the benefit of the filing date of any of the Patents listed on Schedule B, and including any and all extensions, supplementary protection certificates and the like with respect to any of the foregoing.

 

“Seller Records” means all pre-clinical, clinical and process development data, studies, reports and books and records in the possession of Seller or its Affiliates relating to research or development of hormone-related sterols for treating medical conditions by Seller or its Affiliates.

 

“Seller’s Knowledge” (and similar phrases) means the actual knowledge of any senior executive officer of Seller or Harbor Diversified, Inc.

 

“Seller Trademark Rights” means the issued, pending and abandoned U.S. and foreign trademarks and trademark applications listed in Schedule C.

 

“Tax” or “Taxes” means any and all taxes, assessments, levies, tariffs, duties or other charges or impositions in the nature of a tax (together with any and all interest, penalties, additions to tax and additional amounts imposed with respect thereto) imposed by any Governmental Authority, including income, estimated income, gross receipts, profits, business, license, occupation, franchise, capital stock, real or personal property, sales, use, transfer, value added, employment or unemployment, social security, disability, alternative or add-on minimum, customs, excise, stamp, environmental, commercial rent or withholding taxes, and shall include any liability for Taxes of any other Person under Applicable Law, as a transferee or successor, by contract or otherwise.

 

 
4
 

 

“Tax Return” means any return, declaration, report, claim for refund, information return or statement relating to Taxes, including any schedule or attachment thereto, filed or maintained, or required to be filed or maintained, in connection with the calculation, determination, assessment or collection of any Tax and shall include any amended returns required as a result of examination adjustments made by the Internal Revenue Service or other Tax authority.

 

“Transfer Taxes” has the meaning set forth in Section 5.2(a).

 

Section 1.2.     Interpretation.

 

(a)     Descriptive headings are for convenience only and shall not control or affect the meaning or construction of any provision of this Agreement.

 

(b)     Except as otherwise expressly provided in this Agreement or as the context otherwise requires, the following rules of interpretation apply to this Agreement: (i) the singular includes the plural and the plural includes the singular; (ii) “or” and “any” are not exclusive and the words “include” and “including,” and variations thereof, shall not be deemed to be terms of limitation, but rather shall be deemed to be followed by the words “without limitation;” (iii) a reference to any contract includes supplements and amendments; (iv) a reference to an Applicable Law includes any amendment or modification to such Applicable Law; (v) a reference to a Person includes its successors, heirs and permitted assigns; (vi) a reference to one gender shall include any other gender; (vii) a reference in this Agreement to an Article, Section, Exhibit or Schedule is to the referenced Article, Section, Exhibit or Schedule of this Agreement; and (viii) “hereunder,” “hereof,” and words of similar import shall be deemed references to this Agreement as a whole and not to any particular Article, Section or other provision.

 

(c)     The Parties hereto agree that they have been represented by counsel during the negotiation, drafting, preparation and execution of this Agreement and, therefore, waive the application of any Applicable Law or rule of construction providing that ambiguities in an agreement or other document will be construed against the Party drafting such agreement or document.

 

ARTICLE II     
PURCHASE AND SALE

 

Section 2.1.     Purchase and Sale of Assets; Purchase Price.

 

(a)     Purchase and Sale of Assets; Purchase Price. Pursuant to the terms and subject to the conditions of this Agreement, on the date hereof, Seller shall (and, as applicable, shall cause its Affiliates to) sell, transfer and assign to Buyer, free and clear of all Liens, and Buyer shall purchase and acquire from Seller (and its Affiliates, as applicable), all of Seller’s right, title and interest in, to and under all of the Acquired Assets. In consideration of the sale, conveyance, delivery, transfer, and assignment of the Acquired Assets to Buyer and Seller’s other covenants and obligations hereunder, on the date hereof, Buyer shall deliver to Seller $2,500,000.00 (the “Purchase Price”), payable by wire transfer of immediately available U.S. funds.

 

 
5
 

 

Section 2.2.     Acquired Assets; Excluded Assets.

 

(a)     Acquired Assets. The term “Acquired Assets” means:

 

(i)     all of Seller’s right, title and interest in and to the Seller Materials;

 

(ii)     all of Seller’s right, title and interest in and to the Purchased Intellectual Property, including all of Seller’s right, title and interest in and to the Seller Patent Rights and all of Seller’s right, title and interest in and to the Seller Trademark Rights;

 

(iii)     Seller’s rights in and to the Assumed Contracts;

 

(iv)     all of Seller’s right, title and interest in and to the Seller Records;

 

(v)     all claims, counterclaims, credits, causes of action, choses in action, rights of recovery, and rights of indemnification or setoff against third-parties and other claims arising out of or relating primarily to any Acquired Assets or the Assumed Liabilities and all other intangible property rights that primarily relate to any Acquired Assets or the Assumed Liabilities; and

 

(vi)     all goodwill of or related to the Purchased Intellectual Property.

 

(b)     Excluded Assets. Notwithstanding Section 2.2(a), Buyer shall not acquire from Seller pursuant to this Agreement any properties and assets of Seller other than the Acquired Assets. If as a result of the transactions contemplated by this Agreement Buyer comes into possession of intangible or physical assets of Seller or its Affiliates, or intangible or physical assets of third parties, Buyer shall promptly notify Seller, and work with Seller in good faith to return such assets to Seller, at Seller’s cost. Nothing in this Agreement shall be construed as an attempt by Seller or its Affiliates to assign any Contract to the extent that such Contract is not assignable without the necessary consent of the other party or parties thereto.

 

Section 2.3.     Assumed Liabilities; Buyer Not Successor to Seller; Excluded Liabilities.

 

(a)     Assumed Liabilities. Pursuant to the terms and subject to the conditions of this Agreement, on the date hereof, Seller shall sell, convey, transfer and assign to Buyer, and Buyer shall assume from Seller, only the Assumed Liabilities. “Assumed Liabilities” means:

 

(i)     any and all liabilities with respect to the Acquired Assets, including without limitation, the Assumed Contracts and any and all liabilities and outstanding payments required to prosecute and maintain the Seller Patent Rights, including in reexamination, reissue, litigation, interference, opposition or nullity actions or the like, arising after the Effective Date;

 

(ii)     any and all liabilities and outstanding payments required to prosecute and maintain the Seller Patent Rights prior to the Effective Date, including in reexamination, reissue, litigation, interference, opposition or nullity actions or the like; provided, however, that Seller shall retain liability for any and all liabilities and obligations required to be paid or performed prior to the Effective Date, to prosecute and maintain Key Assets, that are due and payable or to have been performed prior to the Effective Date; and

 

(iii)     any and all liabilities with respect to planned or ongoing clinical trial activities relating to the Purchased Intellectual Property.

 

 
6
 

 

(b)     Buyer Not Successor to Seller. Notwithstanding anything herein to the contrary, in no event shall Buyer be deemed to have assumed any liability or obligation (including a liability or obligation that, but for this sentence, would be deemed to be an Assumed Liability) where the existence or nature of such liability or obligation constitutes or arises out of a breach or inaccuracy of any representation or warranty or the non-fulfillment or breach of any covenant, agreement or obligation of Seller hereunder.

 

(c)     Excluded Liabilities. Buyer shall not be the successor to Seller, and Buyer expressly does not assume and shall not become liable to pay, perform or discharge, any liability, obligation or commitment whatsoever of Seller or of any of the Acquired Assets other than the Assumed Liabilities. All liabilities, obligations or commitments other than the Assumed Liabilities are referred to herein as the “Excluded Liabilities.” Seller shall pay, perform and discharge when due, all of the Excluded Liabilities.

 

ARTICLE III     
REPRESENTATIONS AND WARRANTIES OF SELLER AND PARENT

 

Seller and Parent, jointly and severally, represent and warrant to Buyer, as of the date hereof, as follows, with each such representation and warranty subject only to such exceptions, if any, as are set forth in the particular disclosure schedule numbered and captioned to correspond to, and referenced in, such representation or warranty:

 

Section 3.1.     Organization. Seller is a corporation duly organized, validly existing and in good standing under the laws of the State of Delaware and has all requisite power and authority to own, lease and operate its properties and to carry on its business as now being conducted.

 

Section 3.2     Authority; Binding Agreements. The execution and delivery by Seller and Parent of this Agreement and the Related Documents to which each is or will become a party and the consummation of the transactions contemplated hereby and thereby have been duly and validly authorized by all necessary action on the part of Seller and Parent, including, but not limited to, any required stockholder approvals. Each of Seller and Parent has all requisite power and authority to enter into this Agreement and the Related Documents to which it is or will become a party and to consummate the transactions contemplated hereby and thereby, and this Agreement and such Related Documents have been, or upon execution and delivery thereof will be, duly executed and delivered by Seller and Parent, as the case may be. This Agreement and the Related Documents to which Seller and Parent are or will become a party are, or upon execution and delivery by Seller and Parent thereof will be, the valid and binding obligations of Seller and Parent, as the case may be, enforceable against Seller and Parent, as the case may be, in accordance with their respective terms, subject to laws of general application relating to the rights of creditors generally.

 

Section 3.3.     Conflicts; Consents. The execution and delivery by Seller and Parent of this Agreement and the Related Documents to which Seller and Parent are or will become a party, the consummation of the transactions contemplated hereby and thereby and compliance by Seller and Parent with any of the provisions hereof and thereof do not and will not conflict with or result in a breach of the certificate of incorporation, bylaws or other constitutive or organizational documents of Seller.

 

Section 3.4.     Governmental Authorizations. No consent, approval or authorization of, or registration, declaration or other similar action in respect of, or filing with, any Governmental Authority is required to be obtained or made by or with respect to Seller or Parent in connection with the execution, delivery and performance of this Agreement, the Related Documents or the consummation of the transactions contemplated hereby and thereby.

 

 
7
 

 

Section 3.5.     Good Title. (i) Seller has good and marketable title to the Purchased Intellectual Property that is set forth on Schedule 3.5 (the “Key Assets”), free and clear of all Liens and has the complete and unrestricted power and unqualified right to sell, convey, deliver, transfer and assign to Buyer, as applicable, the Key Assets; (ii) there are no adverse claims of ownership to the Key Assets; (iii) Seller has not received written notice that any Person has asserted a claim of ownership or right of possession or use in or to any of the Key Assets; (iv) to the Seller’s Knowledge, Seller’s use of the Key Assets does not violate, infringe, misappropriate, misuse or otherwise conflict with any intellectual property rights of any Person; (v) except as set forth on Schedule 3.5 relating to WO/PCT applications, none of the Key Assets have been cancelled, abandoned or otherwise terminated and all renewal and maintenance fees in respect thereof that are due and payable prior to the Effective Date have been duly paid; and (vi)  to the Seller’s Knowledge, Seller has the exclusive right to file, prosecute and maintain all applications and registrations with respect to the Key Assets. Buyer will acquire from Seller, good and marketable title to all of the Key Assets, free and clear of all Liens.

 

Section 3.6.     Litigation. There is no Action pending, or to Seller’s Knowledge, threatened before any Governmental Authority, and there is no claim, investigation or administrative action of any Governmental Authority pending, or to Seller’s Knowledge, threatened, that affects Seller or Parent or the Acquired Assets or that could reasonably be expected to result in restraining, enjoining or otherwise preventing the completion by Seller or Parent of the transactions contemplated by this Agreement or the Related Documents, nor has Seller been notified in writing of any reasonable basis on which any Action may be brought in the future that affects Seller, nor has Seller been notified of any reasonable basis on which any Action may be brought in the future that adversely affects the Acquired Assets. There is no outstanding Order of any Governmental Authority against Seller relating to the Acquired Assets or that delays the ability of Seller to perform its obligations hereunder or under any Related Document.

 

Section 3.7.     Disclaimers.

 

(a)     IT IS UNDERSTOOD AND AGREED THAT, UNLESS EXPRESSLY STATED IN THIS AGREEMENT, SELLER IS NOT MAKING AND HAS NOT AT ANY TIME MADE ANY WARRANTIES OR REPRESENTATIONS OF ANY KIND OR CHARACTER, EXPRESS OR IMPLIED, WITH RESPECT TO THE ACQUIRED ASSETS, INCLUDING BUT NOT LIMITED TO, ANY WARRANTIES OR REPRESENTATIONS AS TO MERCHANTABILITY, FITNESS FOR A PARTICULAR PURPOSE, VALIDITY, ENORCEABILITY OR NON-INFRINGEMENT. BY WAY OF CLARIFICATION, NOTHING IN THIS AGREEMENT SHALL BE DEEMED TO BE A REPRESENTATION AS TO VALIDITY, ENFORCEABILITY AND, EXCEPT AS SET FORTH IN SECTION 3.5(IV), NON-INFRINGEMENT.

 

(b)     BUYER ACKNOWLEDGES AND AGREES THAT EXCEPT AS OTHERWISE SET FORTH IN THIS AGREEMENT UPON CLOSING SELLER SHALL SELL AND CONVEY ALL OF ITS RIGHT, TITLE AND INTEREST IN AND TO THE ACQUIRED ASSETS TO BUYER AND BUYER SHALL ACCEPT THE ACQUIRED ASSETS “AS IS, WHERE IS, WITH ALL FAULTS.” BUYER HAS NOT RELIED AND WILL NOT RELY ON, AND SELLER IS NOT LIABLE FOR OR BOUND BY, ANY EXPRESS OR IMPLIED WARRANTIES, GUARANTEES, STATEMENTS, REPRESENTATIONS OR INFORMATION PERTAINING TO THE ACQUIRED ASSETS OR RELATING THERETO MADE OR FURNISHED BY SELLER OR ITS REPRESENTATIVES, TO WHOMEVER MADE OR GIVEN, DIRECTLY OR INDIRECTLY, ORALLY OR IN WRITING, EXCEPT AS EXPRESSLY STATED IN THIS AGREEMENT. BUYER ALSO ACKNOWLEDGES THAT THE PURCHASE PRICE REFLECTS AND TAKES INTO ACCOUNT THAT THE ACQUIRED ASSETS ARE BEING SOLD “AS IS, WHERE IS, WITH ALL FAULTS.”

 

 
8
 

 

(c)     BUYER ACKNOWLEDGES THAT SOME OR ALL OF THE SELLER PATENT RIGHTS NOT PART OF THE KEY ASSETS AND THE SELLER TRADEMARK RIGHTS HAVE BEEN ABANDONED, EXPIRED, OR ARE OTHERWISE NO LONGER VALID. BY WAY OF CLARIFICATION, WITH RESPECT TO SELLER PATENT RIGHTS AND SELLER TRADEMARK RIGHTS NOT LISTED ON SCHEDULE 3.5, THE INCLUSION OF SUCH RIGHTS NOT PART OF THE KEY ASSETS ON SCHEDULE B OR SCHEDULE C IS NOT TO BE CONSTRUED AS A REPRESENTATION OR WARRANTY AS TO THEIR EXISTENCE.

 

(d)     EXCEPT FOR ANY EXPRESS OBLIGATIONS OF THE SELLER SET FORTH IN THIS AGREEMENT, THE SELLER HAS NO FURTHER OBLIGATIONS WITH RESPECT TO THE ACQUIRED ASSETS.

 

(e)     BUYER ACKNOWLEDGES THAT SOME OF THE ACQUIRED ASSETS MAY CONTAIN THIRD-PARTY INTELLECTUAL PROPERTY THAT MAY HAVE BEEN LICENSED BY SELLER OR OTHERWISE ACQUIRED BY SELLER. BUYER UNDERSTANDS THAT SELLER MAY BE UNABLE TO TRANSFER INTELLECTUAL PROPERTY BELONGING TO, OWNED OR OTHERWISE RESTRICTED BY A THIRD-PARTY WITHOUT THE EXPRESS WRITTEN CONSENT OF THAT PARTY, WHICH WILL NOT BE OBTAINED OR SOUGHT BY SELLER AS A PART OF THIS AGREEMENT.

 

ARTICLE IV     
REPRESENTATIONS AND WARRANTIES OF BUYER

 

Buyer represents and warrants to Seller and Parent, as of the date hereof, as follows:

 

Section 4.1.     Organization, Standing and Power. Buyer is a limited liability company duly organized, validly existing and in good standing under the laws of the state of its organization and has all requisite power and authority to own, lease and operate its properties and to carry on its business as now being conducted.

 

Section 4.2.     Authority; Binding Agreements. The execution and delivery by Buyer of this Agreement and the Related Documents to which it is or will become a party and the consummation of the transactions contemplated hereby and thereby have been duly and validly authorized by all necessary action on the part of Buyer. Buyer has all requisite power and authority to enter into this Agreement and the Related Documents to which it is or will become a party and to consummate the transactions contemplated hereby and thereby, and this Agreement and such Related Documents have been, or upon execution and delivery thereof will be, duly executed and delivered by Buyer. This Agreement and the Related Documents to which Buyer is or will become a party are, or upon execution and delivery thereof will be, the valid and binding obligations of Buyer, enforceable against Buyer in accordance with their respective terms, subject to laws of general application relating to the rights of creditors generally.

 

 
9
 

 

Section 4.3.     Litigation. There is no Action pending, or to Buyer’s Knowledge, threatened before any Governmental Authority, and there is no claim, investigation or administrative action of any Governmental Authority pending, or to Buyer’s Knowledge, threatened, that could reasonably be expected to result in restraining, enjoining or otherwise preventing the completion by Buyer of the transactions contemplated by this Agreement or the Related Documents.

 

ARTICLE V     
ADDITIONAL AGREEMENTS

 

Section 5.1.     Confidentiality.

 

(a)     Buyer Confidentiality Agreement. Buyer shall and shall cause its Affiliates and its and their respective officers, directors, employees, counsel, accountants, financial advisors, lenders and other agents and representatives (collectively, “Representatives”) to: (i) protect the Seller Confidential Information with at least the same degree of care, but no less than reasonable care, with which it protects its own most sensitive confidential information and not disclose or reveal any Seller Confidential Information to any Person other than to Buyer’s or its Affiliates’ respective Representatives, including financial advisors, current and prospective lenders and investors who need to know Seller Confidential Information in connection with the performance of this Agreement or any document to be delivered hereunder or for the purpose of evaluating the transactions contemplated hereby, except to the extent that disclosure of such Seller Confidential Information has been consented to in writing by Seller; and (ii) not use Seller Confidential Information for any purpose other than (A) in connection with the evaluation or consummation of the transactions contemplated by this Agreement; (B) to enforce Buyer’s rights and remedies under this Agreement; or (C) as required to be disclosed under Applicable Law (provided, that prompt notice of such disclosure will be given as far in advance as reasonably possible to Seller to give Seller an opportunity to determine whether disclosure is required and to assess the extent of Seller Confidential Information required to be disclosed). Buyer acknowledges that certain aspects of the Seller Confidential Information may constitute material non public information and, therefore, Buyer shall not, and shall cause its Affiliates and its and their Representatives not to, trade in the securities of the Seller’s Affiliates. The obligations of Buyer under this Section 5.1(a) shall survive the Effective Date.

 

(b)     Interpretation. Buyer acknowledges and agrees that the provisions of this Section 5.1 are necessary and reasonable to protect Seller and are a material inducement to Seller’s execution and delivery of this Agreement. Buyer hereby waives any right to assert that any provision of law renders the restrictions contained in this Section 5.1 as invalid, illegal or unenforceable in any respect.

 

(c)     Equitable Relief. Buyer acknowledges and agrees that a breach of this Section 5.1 may cause irreparable damage and great loss to Seller or its Affiliates, the exact amount of which will be difficult to ascertain, and that the remedies at law for any such breach may be inadequate. Accordingly, Buyer acknowledges and agrees that in the event of such a breach, Seller shall be entitled to seek equitable relief, including injunctive relief, without posting bond or other security and without a showing of the inadequacy of monetary damages as a remedy.

 

 
10
 

 

Section 5.2.     Certain Tax Matters.

 

(a)     Transfer Taxes. All recordation, transfer, documentary, excise, sales, value added, use, stamp, conveyance or other similar Taxes, duties or governmental charges, and all recording or filing fees or similar costs, imposed or levied by reason of, in connection with or attributable to this Agreement and the Related Documents or the transactions contemplated hereby and thereby (collectively, “Transfer Taxes”) shall be borne equally by Seller and Buyer; provided, however, that Buyer and Seller shall reasonably cooperate with one another to lawfully minimize such Taxes. In the case of Transfer Taxes for which Buyer is liable to the applicable taxing authority, on the Effective Date Seller shall pay to Buyer 50% of the amount of such Transfer Taxes as reasonably estimated by Buyer, with subsequent additional payments by Seller to Buyer or refunds by Buyer to Seller of amounts previously paid by Seller in the event it is subsequently determined that the amount of the subject Transfer Taxes was more or less than the estimated amounts.

 

(b)     Tax Withholding. Buyer and Seller agree that all payments under this Agreement will be made without any deduction or withholding for or on account of any Taxes or other amounts unless required by Applicable Law. In the event Buyer determines that it is required under Applicable Law to withhold and pay any Tax to any revenue authority in respect of any payments made to Seller, the amount of such Tax shall be deducted by Buyer and paid to the relevant revenue authority, and Buyer shall notify Seller thereof and shall promptly furnish to Seller all copies of any Tax certificate or other documentation evidencing such withholding. Buyer shall not be required to pay any additional amounts to Seller in respect of any amounts paid to any revenue authority pursuant to the immediately preceding sentence. In the event that any withholding Tax shall subsequently be found to be due, payment of such Tax shall be the responsibility of Seller. The Parties agree to reasonably cooperate with each other, including by completing or filing documents required under the provisions of any applicable income tax treaty or Applicable Law, to claim any applicable exemption from, or reduction of, any such applicable Taxes.

 

(c)     Bulk Sales. Seller and Buyer hereby waive compliance with any Applicable Laws with respect to “bulk sales” applicable to the sale to Buyer of the Acquired Assets by Seller.

 

(d)     Cooperation and Exchange of Information. Each of Seller and Buyer shall provide the other with such assistance as may reasonably be requested by the other Party in connection with the preparation of any Tax Return.

 

Section 5.3.     Cooperation in Patent Transfer and Assignment. Upon the reasonable request of Buyer, and at Buyer’s sole expense, Seller and its patent attorneys and agents will cooperate with Buyer following the Effective Date to prepare any additional documentation required to record and give effect to the assignment of the Purchased Intellectual Property in accordance with this Agreement. In addition, upon the reasonable request of Buyer, Seller will cooperate with Buyer as Buyer compiles docketing information relating to the Key Assets, and in connection therewith, will forward correspondence it receives relating to the Key Assets to Buyer promptly, and as reasonably requested by Buyer, will contact the United States Patent and Trademark Office and foreign associates to change the addressee of their correspondence relating to Key Assets to Buyer.

 

Section 5.4.     Compliance with Laws. Each Party shall perform, and shall ensure that its Affiliates, sublicensees and contractors perform, the activities for which such Party is responsible under this Agreement and all other activities required or permitted under this Agreement in compliance, in all material respects, with all Applicable Laws and regulations.

 

 
11
 

 

Section 5.5.     Further Assurances. Each Party shall, and shall cause its Affiliates to, at any time and from time to time, upon the request of the other Parties, and at the requesting Party’s expense, execute, acknowledge, deliver and file, or cause to be executed, acknowledged, delivered and filed, all such further documents as may be reasonably required for carrying out the purposes of this Agreement and the Related Documents and the consummation of the transactions contemplated hereby and thereby.

 

ARTICLE VI     
CONDITIONS PRECEDENT TO CLOSING

 

Section 6.1.     Conditions Precedent to the Obligations of Buyer. The obligation of the Buyer to consummate the transactions described in this Agreement and any and all liability of the Buyer to the Seller shall be subject to the fulfillment on or before the closing of the following conditions precedent, each of which may be waived by the Buyer in its sole discretion:

 

(a)     Closing Documents. The Seller shall have delivered to the Buyer (i) an Intellectual Property Transfer and Assignment Agreement in substantially the form of Exhibit A attached hereto, (ii) a Xxxx of Sale in substantially the form of Exhibit B attached hereto, and (iii) such other documents and instruments as the Buyer or its counsel may reasonably request.

 

Section 6.2.     Conditions Precedent to the Obligations of Seller. The obligation of the Seller to consummate the transactions described in this Agreement and any and all liability of the Seller to the Buyer shall be subject to the fulfillment on or before the closing of the following conditions precedent, each of which may be waived by the Seller in its sole discretion:

 

(a)     Closing Documents. The Buyer shall have delivered to the Seller (i) the Assignment and Assumption Agreement substantially in the form of Exhibit C attached hereto, pursuant to which, subject to the provisions of Section 2.3, it shall assume and agree to pay, perform and discharge the Assumed Liabilities and (ii) such other documents and instruments as the Seller or its counsel may reasonably request.

 

ARTICLE VII     
INDEMNIFICATION AND LIMITATION OF LIABILITY

 

Section 7.1.     Indemnification by Seller and Parent. Seller and Parent hereby agree to, jointly and severally, indemnify, defend and hold harmless Buyer and any of its Affiliates or Representatives (collectively, “Purchaser Indemnitee”), from and against any and all losses, liabilities, damages, judgments, costs and expenses, including, without limitation, attorneys' fees and court costs resulting from any claim asserted, action or suit (“Claims”) brought by third-parties against Purchaser Indemnitees arising out of or related to: (i) Seller’s use of the Acquired Assets before the Effective Date; (ii) Seller’s gross negligence or willful misconduct; (iii) breach of Seller’s or Parent’s obligations under this Agreement, including Seller’s and Parent’s representations and warranties; or (iv) Seller’s failure to comply with any Applicable Laws with respect to “bulk sales” applicable to the sale to Buyer of the Acquired Assets by Seller.

 

Section 7.2.     Indemnification by Buyer. Buyer hereby agrees to indemnify, defend and hold harmless Seller, Parent and any of their Affiliates and Representatives (collectively, “Seller Indemnitee”), from and against any and all Claims brought by third-parties against Seller Indemnitees arising out of or due to: (i) Buyer’s use of the Acquired Assets after the Effective Date; (ii) Buyer’s gross negligence or willful misconduct; or (iii) breach of Buyer’s obligations under this Agreement, including Buyer’s representations and warranties.

 

 
12
 

 

Section 7.3.     Limitation of Liability. Except (i) for claims arising under Section 5.1 and (ii) with regard to each Party’s obligation of indemnification of the other Party as expressed in Sections 7.1 and 7.2 above, in no event shall any Party be liable to the other for any special, indirect, consequential, incidental or punitive damages arising out of or in connection with this Agreement, including loss of revenue, loss of actual or anticipated profits, loss of use of money, loss of opportunity, loss of anticipated savings, loss of business, damage to corporate image, reputation or goodwill, whether based upon principles of contract, negligence, tort or otherwise, or for such claims or demands made by any third-parties, even if that Party is advised of the possibility of such loss or damages. Regardless of the forum and regardless of whether any action or claim is based on contract, tort, or otherwise, in no event will Seller’s and/or its Affiliates’ total liability arising out of or in connection with this Agreement and the transactions contemplated by this Agreement exceed $750,000.00 (the “Initial Cap”); provided, however, in the case of a claim arising as a result of any inaccuracy in or breach of any of the representations or warranties of Seller or Parent contained in Sections 3.2 or 3.5 (the “Key Reps”), Seller’s total liability may exceed the Initial Cap by the amount of recoverable losses that result from such inaccuracies in or breach of the Key Reps, but then, regardless of the forum and regardless of whether any action or claim is based on contract, tort, or otherwise, in no event will Seller’s total liability arising out of or in connection with this Agreement and the transactions contemplated by this Agreement exceed $2,500,000.00. The existence of more than one action or claim will not enlarge or extend this limit.

 

ARTICLE VIII     
MISCELLANEOUS

 

Section 8.1.     Survival of Representations and Warranties. Subject to the limitations and other provisions of this Agreement, the representations and warranties contained herein shall survive the closing and shall remain in full force and effect until the date that is twelve (12) months from the Effective Date; provided, however, that the representations and warranties contained in Sections 3.2 and 3.5 shall remain in full force and effect until the date that is five (5) years from the Effective Date. All covenants and agreements of the parties contained herein shall survive the closing indefinitely or for the period explicitly specified therein. For the avoidance of doubt, the Parties hereby agree and acknowledge that the survival period set forth in this Section 8.1 is a contractual statute of limitations and that any claim brought by any Party for a breach of a representation or warranty must be brought on or prior to the expiration of the survival period. Notwithstanding the foregoing, any claims asserted in good faith with reasonable specificity (to the extent known at such time) and in writing by notice from the non-breaching Party to the breaching Party prior to the expiration date of the applicable survival period shall not thereafter be barred by the expiration of the relevant representation or warranty and such claims shall survive until finally resolved.

 

Section 8.2.     Governing Law. Construction and interpretation of this Agreement shall be governed by the laws of the State of New York, excluding any conflicts or choice of law rule or principle that might otherwise refer construction or interpretation of this Agreement to the substantive Applicable Law of another jurisdiction.

 

Section 8.3.     Notices. All notices, requests, demands and other communications that are required or may be given pursuant to the terms of this Agreement shall be in written form, and shall be deemed delivered (a) on the date of delivery when delivered by hand on a Business Day, (b) on the Business Day designated for delivery if sent by reputable overnight courier maintaining records of receipt and (c) on the date of transmission when sent by facsimile, electronic mail or other electronic transmission during normal business hours on a Business Day, with confirmation of transmission by the transmitting equipment; provided, however, that any such communication delivered by facsimile or other electronic transmission shall only be effective if within two Business Days of such transmission such communication is also delivered by hand or deposited with a reputable overnight courier maintaining records of receipt for delivery on the Business Day immediately succeeding such day of deposit. All such communications shall be addressed to the Parties at the address set forth as follows, or at such other address as a Party may designate upon ten (10) days’ prior written notice to the other Parties.

 

 
13
 

 

If to Buyer, to:

 

[_______________]

[_______________]

[_______________]

Attention: [_______________]

Facsimile:  [_______________]

 

with a copy (which shall not constitute notice) to:

 

[_______________]

[_______________]

[_______________]

Attention: [______________]

Facsimile:  [______________]

 

If to Seller to:

 

Harbor Therapeutics, Inc.

x/x Xxxxxxxxx Xxxxx Xxxxxxx & Xxxxx, X.X.

0000 Xxxxxxxxx Xxxxx, Xxxxx 0000

Xxx Xxxxx, XX 00000

Attention: Xxxx Xxxxx

Facsimile: (000) 000-0000

 

If to Parent, to:

 

Harbor Diversified, Inc.

x/x Xxxxxxxxx Xxxxx Xxxxxxx & Xxxxx, X.X.

0000 Xxxxxxxxx Xxxxx, Xxxxx 0000

Xxx Xxxxx, XX 00000

Attention: Xxxx Xxxxx

Facsimile: (000) 000-0000

 

Section 8.4.     Benefits of Agreement. All of the terms and provisions of this Agreement shall be binding upon and inure to the benefit of the Parties hereto and their respective successors (including any direct or indirect successor by purchase, merger, consolidation or otherwise to all or substantially all of the business and/or assets of the Company) and permitted assigns. Each Party shall require and cause any successor (whether direct or indirect by purchase, merger, consolidation or otherwise) to all, substantially all or a substantial part of the business and/or assets of such Party, by written agreement in form and substances satisfactory to the other Party, expressly to assume and agree to perform such Party’s indemnification obligations pursuant to this Agreement in the same manner and to the same extent that such Party would be required to perform if no such succession had taken place. This Agreement is for the sole benefit of the Parties hereto and not for the benefit of any third-Person.

 

 
14
 

 

Section 8.5.     Amendments and Waivers. No modification, amendment or waiver of any provision of, or consent or approval required by, this Agreement, nor any consent to or approval of any departure herefrom, shall be effective unless it is in writing and signed by the Party against whom enforcement of any such modification, amendment, waiver, consent or approval is sought. Such modification, amendment, waiver, consent or approval shall be effective only in the specific instance and for the purpose for which given. Neither the failure of any Party to enforce, nor the delay of any Party in enforcing, any condition or part of this Agreement at any time shall be construed as a waiver of that condition or part or forfeit any rights to future enforcement thereof. No action taken pursuant to this Agreement, including any investigation by or on behalf of any Parties hereto, shall be deemed to constitute a waiver by the Party taking action of compliance by the other Party with any representation, warranty, covenant, agreement or obligation contained herein.

 

Section 8.6.     Cumulative Rights. Except as expressly provided herein, the various rights under this Agreement shall be construed as cumulative, and no one of them is exclusive of any other or exclusive of any rights allowed by Applicable Law.

 

Section 8.7.     Expenses. Each Party shall be responsible for and bear its own costs and expenses with respect to the transactions contemplated herein.

 

Section 8.8.     Arbitration.

 

(a)     Except as otherwise expressly provided in this Agreement, any disputes, claims or controversies arising between the Parties relating to, arising out of or in any way connected with this Agreement or any term or condition hereof, or the performance by either Party of its obligations hereunder, shall be promptly presented to the Chief Executive Officers of Buyer and Seller (or alternative officers designated by Buyer or Seller) for resolution and if such officers cannot promptly resolve such disputes, claims or controversies then such dispute, claim or controversy shall be finally resolved by binding arbitration. Whenever a Party shall decide to institute arbitration proceedings, it shall give written notice to that effect to the other Party. The Party giving such notice shall refrain from instituting the arbitration proceedings for a period of sixty (60) days following such notice.

 

(b)     Any arbitration hereunder shall be conducted before JAMS, Inc. (“JAMS”), or its successor. The arbitration shall be conducted before a single arbitrator and shall be conducted in accordance with the rules and regulations promulgated by JAMS unless specifically modified herein. The arbitration shall be located in New York City, New York. The arbitrator shall have the authority to grant specific performance, and to allocate among the Parties the costs of arbitration in such equitable manner as he or she determines.

 

(c)     The parties covenant and agree that the arbitration shall commence within ninety (90) days of the date on which a written demand for arbitration is filed by any Party (the “Filing Date”). In connection with the arbitration proceeding, the arbitrator shall have the power to order the production of documents by each Party and any third-party witnesses. In addition, each Party may take up to three (3) depositions as of right, and the arbitrator may in his or her discretion allow additional depositions upon good cause shown by the moving party. However, the arbitrator shall not have the power to order the answering of interrogatories or the response to requests for admission. In connection with any arbitration, each Party shall provide to the others, no later than seven (7) Business Days before the date of the arbitration, the identity of all persons that may testify at the arbitration and a copy of all documents that may be introduced at the arbitration or considered or used by a Party’s witnesses or experts. The arbitrator’s decision and award shall be made and delivered within thirty (30) days of the closing of the arbitration hearing. The arbitrator’s decision shall set forth a reasoned basis for any award of damages or finding of liability.

 

 
15
 

 

(d)     The Parties covenant and agree that they will participate in the arbitration in good faith. Any Party unsuccessfully refusing to comply with an order of the arbitrator shall be liable for costs and expenses, including attorneys’ fees, incurred by the other Parties in enforcing the award. Notwithstanding anything to the contrary contained in this Agreement, this Section 8.8 shall not apply to any request by any Party to this Agreement for temporary, preliminary or permanent injunctive relief or other forms of equitable relief.

 

(e)     Judgment upon the award so rendered may be entered in any court having jurisdiction or application may be made to such court for judicial acceptance of any award and an order of enforcement, as the case may be.

 

Section 8.9.     Assignment. This Agreement and the rights and obligations hereunder shall not be assignable or transferable by any Party hereto without the prior written consent of the other Parties hereto, which consent will not be unreasonably withheld; provided, however, that, upon prior written notice to the other Parties, any Party may assign, sublicense, subcontract or delegate this Agreement and any or all of its rights and obligations under this Agreement (i) to any of its Affiliates, (ii) in connection with a merger, consolidation, sale of substantially all of such Party’s assets or (iii) otherwise by operation of Applicable Law without the prior written consent of the other Parties. Any attempted assignment, sublicense, subcontract or delegation in violation of this Section 8.9 shall be null and void.

 

Section 8.10.     Enforceability; Severability. If any covenant or provision hereof is determined to be void or unenforceable in whole or in part, it shall not be deemed to affect or impair the validity of any other covenant or provision hereof if the rights and obligations of a Party hereto will not be materially and adversely affected, each of which is hereby declared to be separate and distinct. If any provision of this Agreement is so broad as to be unenforceable, such provision shall be interpreted to be only so broad as is enforceable. If any provision of this Agreement is declared invalid or unenforceable for any reason other than overbreadth, the Parties hereto agree to modify the offending provision so as to maintain the essential benefits of the bargain (including the rights and obligations hereunder) among the Parties to the maximum extent possible, consistent with Applicable Law and public policy.

 

Section 8.11.     Entire Agreement. This Agreement, together with the Schedules and Exhibits expressly contemplated hereby and attached hereto, the Related Documents and the other agreements, certificates and documents delivered in connection herewith or otherwise in connection with the transactions contemplated hereby and thereby, contain the entire agreement among the Parties with respect to the transactions contemplated by this Agreement and supersede all prior agreements or understandings among the Parties with respect to the subject matter hereof.

 

 
16
 

 

Section 8.12.     Publicity. Neither Buyer on the one hand, nor Seller or Parent on the other hand, shall without the written consent of the other (the giving of which consent shall be at the sole discretion of that Party) advertise, publicly announce or provide to any other person information relating to the existence or details of this Agreement or the transactions contemplated thereby.

 

Section 8.13.     Counterparts. This Agreement may be executed in any number of counterparts, and each such counterpart hereof shall be deemed to be an original instrument, but all such counterparts together shall constitute but one agreement. Delivery of an executed counterpart of a signature page of this Agreement by facsimile or other electronic transmission shall be effective as delivery of a manually executed original counterpart of this Agreement.

 

[Remainder of Page Intentionally Left Blank; Signature Page Follows]

 

 
17
 

 

IN WITNESS WHEREOF, the Parties have executed this Agreement as of the day and year first above written.

  

 

Reserva, LLC  

 

 

 

 

 

 

 

 

 

By:

  

 

 

Name: 

Xxxxxx Xxxxxx 

 

 

Title:

Chairman & Managing Member

 

 

 

 

 

 

 

 

 

 

Harbor Therapeutics, Inc.  

 

 

 

 

 

 

 

 

 

By: 

/s/ Xxxxxxxxx Xxxxx 

 

 

Name:    

Xxxxxxxxx Xxxxx

 

 

Title:  

Chairman

 

 

 

 

 

 

 

 

 

 

Harbor Diversified, Inc.  

 

 

 

 

 

 

 

 

 

By:

/s/ Xxxxxxxxx Xxxxx  

 

 

Name: 

Xxxxxxxxx Xxxxx 

 

 

Title:  

Chairman

 

 

 

[Signature Page to Asset Purchase Agreement]

 

 
 

 

SCHEDULE A

 

SELLER MATERIALS

 

 

 
 
 

 

 

 

 
 
 

 

SCHEDULE B

 

SELLER PATENT RIGHTS

 

U.S. Patent Office Customer No. 26551

Patent applications and issued patents

 

Application

Patent No.

Publication No.

Attorney

Docket No.

Filing or 371(c) Date

PCT/US13/70754 

-

-

354.2 WO

11-19-2013

PCT/US00/26848

-

-

  

09-28-2000

PCT/US13/50768

-

-

353.2 WO

07-16-2013

PCT/US11/65552

-

-

348.2 WO

12-16-2011

PCT/US11/65482

-

-

350.1 WO

12-16-2011

PCT/US11/65298

-

-

346.1 WO

12-15-2011

PCT/US10/58449

-

-

351.5 WO

11-30-2010

PCT/US09/58260

-

-

345.5 WO

09-24-2009

PCT/US09/46477

-

-

342.1 WO

06-05-2009

PCT/US09/39567

-

-

340.1 WO

04-03-2009

PCT/US09/33280

-

-

338.2 WO

02-05-2009

PCT/US08/73933

-

-

333.1WO

08-21-2008

PCT/US07/67235

-

-

323.6 WO

04-23-2007

PCT/US05/35786

-

-

318.3 WO

10-03-2005

PCT/US05/35020

-

-

314.3 WO

09-29-2005

PCT/US04/09739

-

-

302.1 WO

03-30-2004

61/775,086

-

-

354.1P

03-08-2013

61/684,140

-

-

359P

08-17-2012

61/672,162

-

-

353P

07-16-2012

61/668,294

-

-

358P

07-05-2012

61/506,517

-

-

354P

07-11-2011

61/495,891

-

-

356.1P

06-10-2011

61/495,305

-

-

356P

06-09-2011

61/493,267

-

-

355P

06-03-2011

61/424,173

-

-

348.1RP

12-17-2010

61/424,156

-

-

350RP

12-17-2010

61/423,457

-

-

346RP

12-15-2010

61/266,483

-

-

351.4P

12-03-2009

61/266,416

-

-

351.3P

12-03-2009

61/266,291

-

-

351.2P

12-03-2009

61/266,092

-

-

351.1P

12-02-2009

  

 
 
 

 

61/265,294

-

-

351P

11-30-2009

61/262,133

-

-

350P

11-17-2009

61/262,101

-

-

348.1P

11-17-2009

61/262,092

-

-

348P

11-17-2009

61/262,076

-

-

346P

11-17-2009

61/261,721

-

-

349P

11-16-2009

61/186,360

-

-

345.4P

06-11-2009

61/184,283

-

-

345.3P

06-04-2009

61/162,620

-

-

345.2P

03-23-2009

61/154,715

-

-

347P

02-23-2009

61/104,083

-

-

344P

10-09-2008

61/100,246

-

-

345.1P

09-25-2008

61/099,880

-

-

345P

09-24-2008

61/093,694

-

-

338.1P

09-02-2008

61/059,714

-

-

341P

06-06-2008

61/059,658

-

-

342P

06-06-2008

61/042,240

-

-

340P

04-03-2008

61/039,902

-

-

339P

03-27-2008

61/026,472

-

-

338 P

02-05-2008

61/026,467

-

-

337P

02-05-2008

60/965,730

-

-

333P

08-21-2007

60/891,222

-

-

328.1P

02-22-2007

60/888,058

-

-

330.1P

02-02-2007

60/885,003

-

-

329.1P

01-15-2007

60/868,042

-

-

323.5P

11-30-2006

60/866,700

-

-

323.4P

11-21-2006

60/866,395

-

-

330P

11-17-2006

60/843,112

-

-

323.1P

09-08-2006

60/829,848

-

-

329P

10-17-2006

60/825,569

-

-

323.2P

09-13-2006

60/825,564

-

-

323.3P

09-13-2006

60/825,389

-

-

328P

09-12-2006

60/821,096

-

-

322.1P

08-01-2006

60/820,700

-

-

324P

07-28-2006

60/793,792

-

-

323P

04-22-2006

60/760,791

-

-

322 P

01-19-2006

60/681,611

-

-

317RP

05-16-2005

60/628,252

-

-

318-2P

11-15-2004

  

 
 
 

 

60/615,307

-

-

318.1P

10-01-2004

60/614,869

-

-

314.2P

09-29-2004

60/609,223

-

-

314.1P

09-09-2004

60/601,835

-

-

314P

08-12-2004

60/588,195

-

-

318P

07-14-2004

60/572,451

-

-

317P

05-18-2004

60/552,452

-

-

202.16P

03-10-2004

60/550,163

-

-

202.15P

03-03-2004

60/479,257

-

-

202.12P

06-17-2003

60/443,282

-

-

281P2

01-27-2003

60/442,496

-

-

256.2P

01-22-2003

60/408,332

-

-

288P

09-04-2002

60/408,287

-

-

289P

09-04-2002

60/407,146

-

-

202.11P

08-28-2002

60/398,516

-

-

202.10P

07-23-2002

60/377,570

-

-

202.9P

05-01-2002

60/351,866

-

-

281P

01-25-2002

60/343,523

-

-

202.7P

12-20-2001

60/343,452

-

-

256.1P

12-20-2001

60/340,054

-

-

202.5P

11-01-2001

60/338,015

-

-

202.6P

11-08-2001

60/328,738

-

-

271P

10-11-2001

60/326,126

-

-

207.4P

09-26-2001

60/323,016

-

-

202.4P

09-11-2001

60/314,704

-

-

258.6P

08-24-2001

60/272,624

-

-

246 P

03-01-2001

60/271,704

-

-

268P

02-26-2001

60/236,920

-

-

256 P

09-28-2000

60/236,919

-

-

255 P

09-28-2000

60/236,114

-

-

254 P

09-28-2000

60/209,405

-

-

216.1P

06-01-2000

60/209,403

-

-

218.1P

06-01-2000

60/190,140

-

-

202.1AP

03-16-2000

60/177,453

-

-

165 P

01-19-2000

60/167,508

-

-

207 P

12-01-1999

60/167,495

-

-

207.2P

12-01-1999

60/166,116

-

-

208.2P

11-16-1999

60/161,453

-

-

214 P

10-25-1999

  

 
 
 

 

60/157,347

-

-

208.1P

09-30-1999

60/157,275

-

-

208P

09-30-1999

60/153,217

-

-

215 P

09-13-1999

60/145,823

-

-

216 P

07-27-1999

60/142,386

-

-

217 P

07-06-1999

60/137,745

-

-

218 P

06-03-1999

60/124,087

-

-

202 P

03-11-1999

60/114,145

-

-

219 P

12-24-1998

60/112,206

-

-

220.P2

12-15-1998

60/110,127

-

-

159 P

11-27-1998

60/109,924

-

-

158 P

11-24-1998

60/109,923

-

-

157 P

11-24-1998

60/107,138

-

-

221 P

11-05-1998

60/095,039

-

-

223.P3

08-03-1998

60/076,662

-

-

223.P2

03-03-1998

60/076,481

-

-

223 P

03-02-1998

60/069,850

-

-

220 P

12-17-1997

60/015,695

-

-

153 P

04-17-1996

14/459,528

-

-

340.1CR

08-14-2014

14/459,493

-

-

340.1DR

08-14-2014

14/027,842

-

US 2014-0018337 A1

202.13C6.1D

09-16-2013

14/027,825

-

US 2014-0018336 A1

202.13C6.1C

09-16-2013

13/943,743

-

-

353.2

07-16-2013

13/919,728

-

US 2013-0338125 A1

338.2D3

06-17-2013

13/919,593

-

US 2013-0345455 A1

338.2D2

06-17-2013

13/919,386

-

US 2013-0345184 A1

338.2D

06-17-2013

13/835,995

-

US 2014-0010806 A1

358.1

03-15-2013

13/734,147

-

US 2013-0164780 A1

335D

01-04-2013

13/664,304

-

US 2013-0066087 A1

342.1D

10-30-2012

13/563,996

-

US 2012-0302537 A1

340.1D

08-01-2012

13/563,982

-

US 2012-0296105 A1

340.1C

08-01-2012

13/328,760

-

US 2012-0252774 A1

348.2

12-16-2011

13/328,374

-

US 2012-0220560 A1

350.1

12-16-2011

13/327,701

-

US 2012-0214987 A1

346.1

12-15-2011

13/306,141

8,367,646

US 2012-0071454 A1

208.3C6C

11-29-2011

13/252,846

-

US 2012-0029260 A1

318.6C

10-04-2011

13/183,275

8,541,600

US 2012-0041016 A1

202.3CC2

07-14-2011

13/107,573

-

US 2011-0218162 A1

202.8DC2

05-13-2011

  

 
 
 

 

13/095,528

8,569,275

US 2011-0212935 A1

202.13C6.1

04-27-2011

13/030,326

8,586,770

US 2011-0137057 A1

314.4C

02-18-2011

12/968,028

-

US 2011-0085984 A1

318.5C

12-14-2010

12/957,661

8,076,316

US 2011-0098260 A1

208.3C6

12-01-2010

12/957,273

-

US 2011-0129423 A1

351.5

11-30-2010

12/905,778

-

US 2011-0028711 A1

302.1C5

10-15-2010

12/792,942

7,906,497

US 2010-0240633 A1

208.3C5

06-03-2010

12/732,164

-

US 2010-0227841 A1

352.1

03-25-2010

12/731,692

-

US 2010-0222315 A1

352

03-25-2010

12/634,455

8,106,036

US 2010-0222313 A1

202.2CC3C1

12-09-2009

12/633,721

7,947,846

US 2010-0222425 A1

202.8DC

12-08-2009

12/571,060

8,022,234

US 2011-0009372 A1

202.3CC

09-30-2009

12/566,565

-

US 2010-0075937 A1

345.5

09-24-2009

12/479,626

8,309,746

US 2009-0326251 A1

342.1

06-05-2009

12/418,559

8,252,947

US 2009-0291933 A1

340.1

04-03-2009

12/406,033

7,842,680

US 2009-0181936 A1

302.1C4

03-17-2009

12/405,970

7,638,509

US 2009-0176752 A1

302.1C3

03-17-2009

12/370,510

8,518,922

US 2009-0291932 A1

338.2

02-12-2009

12/272,767

8,486,926

US 2009-0143349 A1

335.2

11-17-2008

12/196,271

-

US 2009-0258850 A1

333.1

08-21-2008

11/942,689

-

US 2008-0153792 A1

335.1

11-19-2007

11/942,664

8,217,025

US 2008-0146532 A1

334.1

11-19-2007

11/941,936

8,354,396

US 2008-0153797 A1

335

11-17-2007

11/941,934

-

US 2008-0221074 A1

334

11-17-2007

11/862,153

7,550,450

US 2008-0070881 A1

302.1D

09-26-2007

11/838,154

7,514,420

US 2008-0004250 A1

302.1C2

08-13-2007

11/837,508

7,462,610

US 2008-0009472 A1

302.1C

08-11-2007

11/835,397

7,863,261

US 2008-0176823 A1

208.3C4

08-07-2007

11/835,394

7,696,189

-

208.3C3

08-07-2007

11/835,367

7,691,835

US 2008-0058301 A1

208.3C2

08-07-2007

11/835,334

7,776,845

US 2008-0021006 A1

208.3C

08-07-2007

11/696,637

-

US 2008-0015174 A1

202.8.1

04-04-2007

11/674,128

7,547,687

US 2007-0275938 A1

202.14C2

02-12-2007

11/674,126

7,482,334

US 2007-0275937 A1

202.14C

02-12-2007

11/564,026

-

US 2007-0275936 A1

202.3C2

11-28-2006

11/552,095

7,723,532

US 2008-0176824 A1

202.2CC3

10-23-2006

11/551,202

-

US 2008-0045490 A1

202.2CC

10-19-2006

11/551,195

-

US 2009-0215737 A1

202.2CC2

10-19-2006

  

 
 
 

 

11/549,875

7,935,839

US 2007-0213309 A1

202.13C6

10-16-2006

11/549,825

-

US 2007-0265236 A1

202.13C5

10-16-2006

11/549,615

-

US 2008-0085873 A1

202.13C4

10-13-2006

11/549,606

-

US 2007-0203107 A1

202.13C3

10-13-2006

11/549,580

7,910,571

US 2008-0090791 A1

202.13C

10-13-2006

11/389,319

-

US 2007-0077203 A1

318.6

03-24-2006

11/389,294

7,910,755

US 2007-0077201 A1

314.4

03-25-2006

11/355,561

-

US 2007-0053832 A1

318.5

02-15-2006

11/242,547

-

US 2006-0088473 A1

318.4

10-03-2005

11/241,678

-

US 2006-0073099 A1

318.3

09-30-2005

11/241,670

-

US 2007-0014719 A1

314.3

09-29-2005

11/234,675

-

US 2006-0079492 A1

202.8D

09-23-2005

10/949,782

-

US 2005-0075321 A1

202.2DC4

09-23-2004

10/949,694

-

US 2005-0256095 A1

202.2DC3

09-23-2004

10/890,490

-

US 2005-0159366 A1

202.2DC2

07-13-2004

10/877,911

-

US 2007-0129282 A1

202.3C

06-24-2004

10/876,957

-

US 2005-0282732 A1

202.2DC

06-24-2004

10/814,503

-

US 2004-0242618 A1

302.1

03-30-2004

10/741,929

-

US 2004-0220161 A1

202.2D6

12-19-2003

10/728,400

-

US 2005-0101581 A1

202.14

12-05-2003

10/651,515

-

US 2004-0138187 A1

202.13

08-28-2003

10/607,415

7,524,835

US 2006-0063749 A1

202.2D5

06-25-2003

10/607,035

-

US 2004-0097406 A1

202.2D4

06-25-2003

10/606,524

-

-

202.2D3

06-25-2003

10/602,330

-

US 2004-0220114 A1

202.2D2

06-23-2003

10/526,321

-

-

202.13 US

-

10/329,065

-

US 2004-0116359 A1

202.2D

12-21-2002

10/319,356

7,396,827

US 2004-0043973 A1

202.2C

12-13-2002

10/087,929

-

US 2003-0083231 A1

202.8

03-01-2002

09/820,483

-

US 2003-0060425 A1

202.3

03-29-2001

09/675,470

-

-

214.2

09-28-2000

09/675,323

-

-

208.3

09-28-2000

09/672,687

-

-

257

09-28-2000

09/586,673

-

-

216.1

06-01-2000

09/586,672

-

-

218.1

06-01-2000

09/535,675

6,667,299

-

202.2

03-23-2000

09/519,437

-

-

159.1A

03-03-2000

09/518,986

-

-

157.1A

03-03-2000

  

 
 
 

 

09/518,779

-

-

158.1A

03-03-2000

09/461,026

-

-

220

12-15-1999

09/449,184

-

-

158.1

11-24-1999

09/449,042

-

-

159.1

11-24-1999

09/449,004

-

-

157.1

11-24-1999

09/423,467

6,384,251

-

231

11-08-1999

09/174,601

-

-

153.2

10-19-1998

08/327,843

5,424,463

-

240.C4

10-24-1994

08/123,151

-

-

240.C2

09-02-1993

07/575,156

-

-

240

08-29-1990

07/182,480

4,956,355

-

150.2

04-15-1988

07/090,637

-

-

150.1

08-27-1987

 

 

Worldwide patent filings 

Country

Application Number

Filing Date

Australia

25741/97

17-Apr-1997

Canada

2251733

17-Apr-1997

Peoples Republic of China

97193912.8

17-Apr-1997

EPC

97917365.5

17-Apr-1997

Hong Kong

99105169.6

00-Xxx-0000

Xxxxxx

126623

00-Xxx-0000

Xxxxx, Xxxxxxxx of

708339/1998

17-Apr-1997

Norway

19984851

17-Apr-1997

Patent Cooperation Treaty

IB97/00414

17-Apr-1997

Patent Cooperation Treaty

EP97/05716

16-Oct-1997

United Xxxxxx xx Xxxxxxx

00000000

00-Xxx-0000

Xxxxxx Xxxxxx of America

60015695

17-Apr-1996

ARIPO

AP/P/01/02182

24-Nov-1999

OAPI

OA20011000127

24-Nov-1999

Australia

17453/00

24-Nov-1999

Australia

2004237812

00-Xxx-0000

Xxxxxxx

99960591.8

00-Xxx-0000

Xxxxxxx

99960591.8

00-Xxx-0000

Xxxxxx

PI9915623-7

24-Nov-1999

Canada

2356539

00-Xxx-0000

Xxxxxxx Xxxxxxxx of China

99813696.4

00-Xxx-0000

Xxxxxx, Xxxxxxxx of

99960591.8

00-Xxx-0000

Xxxxxxx

99960591.8

24-Nov-1999

EPC

99960591.8

00-Xxx-0000

Xxxxxxx

99960591.8

00-Xxx-0000

Xxxxxx

99960591.8

00-Xxx-0000

Xxxxxxx

99960591.8

00-Xxx-0000

Xxxxxx

99960591.8

24-Nov-1999

Hong Kong

02105184.3

12-Jul-2002

  

 
 
 

 

Indonesia

W-00200101128

00-Xxx-0000

Xxxxxxxxx

W-00200801236

24-Nov-1999

Ireland

99960591.8

00-Xxx-0000

Xxxxxx

142941

00-Xxx-0000

Xxxxx

99960591.8

00-Xxx-0000

Xxxxx

2000-584896

00-Xxx-0000

Xxxxx, Xxxxxxxx of

7006523/2001

00-Xxx-0000

Xxxxx, Xxxxxxxx of

7026568/2006

15-Dec-2006

Luxembourg

99960591.8

00-Xxx-0000

Xxxxxx

a/2001/005166

24-Nov-1999

Monaco

99960591.8

00-Xxx-0000

Xxxxxxxxxxx

99960591.8

24-Nov-1999

New Zealand

511720

24-Nov-1999

Patent Cooperation Treaty

US99/28079

24-Nov-1999

Patent Cooperation Treaty

IB99/01879

24-Nov-1999

Portugal

99960591.8

00-Xxx-0000

Xxxxxxxxx

200102430-6

00-Xxx-0000

Xxxxx Xxxxxx

2001/3852

00-Xxx-0000

Xxxxx

99960591.8

00-Xxx-0000

Xxxxxx

99960591.8

00-Xxx-0000

Xxxxxxxxxxx

99960591.8

00-Xxx-0000

Xxxxxx Xxxxxxx

99960591.8

00-Xxx-0000

Xxxxxx Xxxxxx of America

09449004

00-Xxx-0000

Xxxxxx Xxxxxx of America

09518986

00-Xxx-0000

Xxxxxx Xxxxxx of America

60109923

24-Nov-1998

ARIPO

AP/P/01/02181

24-Nov-1999

OAPI

OA20011000128

24-Nov-1999

Australia

00000/00

00-Xxx-0000

Xxxxxxx

99965050.0

00-Xxx-0000

Xxxxxxx

99965050.0

00-Xxx-0000

Xxxxxx

PI9915644-0

24-Nov-1999

Canada

2352205

00-Xxx-0000

Xxxxxxx Xxxxxxxx of China

99813658.1

00-Xxx-0000

Xxxxxx, Xxxxxxxx of

99965050.0

00-Xxx-0000

Xxxxxxx

99965050.0

24-Nov-1999

EPC

99965050.0

00-Xxx-0000

Xxxxxxx

99965050.0

00-Xxx-0000

Xxxxxx

99965050.0

00-Xxx-0000

Xxxxxx

AP/P/01/02181

00-Xxx-0000

Xxxxxxx

99965050.0

24-Nov-1999

Ghana

AP/P/01/02181

00-Xxx-0000

Xxxxxx

99965050.0

24-Nov-1999

Hong Kong

02102267.0

25-Mar-2002

Indonesia

W-00200101129

24-Nov-1999

Ireland

99965050.0

00-Xxx-0000

Xxxxxx

142942

00-Xxx-0000

Xxxxx

99965050.0

00-Xxx-0000

Xxxxx

2000584873

00-Xxx-0000

Xxxxx

AP/P/01/02181

00-Xxx-0000

  

 
 
 

 

Xxxxx, Xxxxxxxx of

7006525/2001

24-May-2001

Lesotho

AP/P/01/02181

00-Xxx-0000

Xxxxxxxxxx

99965050.0

24-Nov-1999

Malawi

AP/P/01/02181

00-Xxx-0000

Xxxxxx

a/2001/005170

24-Nov-1999

Monaco

99965050.0

00-Xxx-0000

Xxxxxxxxxxx

99965050.0

24-Nov-1999

New Zealand

511721

24-Nov-1999

Patent Cooperation Treaty

US99/28082

24-Nov-1999

Patent Cooperation Treaty

IB99/01877

24-Nov-1999

Portugal

99965050.0

00-Xxx-0000

Xxxxxx Xxxxx

XX/X/00/00000

00-Xxx-0000

Xxxxxxxxx

200102440-5

00-Xxx-0000

Xxxxx Xxxxxx

2001/3847

00-Xxx-0000

Xxxxx

99965050.0

24-Nov-1999

Sudan

AP/P/01/02181

00-Xxx-0000

Xxxxxxxxx

AP/P/01/02181

00-Xxx-0000

Xxxxxx

99965050.0

00-Xxx-0000

Xxxxxxxxxxx

99965050.0

00-Xxx-0000

Xxxxxxxx, Xxxxxx Xxxxxxxx of

AP/P/01/02181

00-Xxx-0000

Xxxxxx

AP/P/01/02181

00-Xxx-0000

Xxxxxx Xxxxxxx

99965050.0

00-Xxx-0000

Xxxxxx Xxxxxx of America

09449184

00-Xxx-0000

Xxxxxx Xxxxxx of America

09518779

00-Xxx-0000

Xxxxxx Xxxxxx of America

60109924

24-Nov-1998

Zimbabwe

AP/P/01/02181

24-Nov-1999

ARIPO

AP/P/01/02167

24-Nov-1999

Canada

2352387

00-Xxx-0000

Xxxxxx

AP/P/01/02167

24-Nov-1999

Ghana

AP/P/01/02167

24-Nov-1999

Kenya

AP/P/01/02167

24-Nov-1999

Lesotho

AP/P/01/02167

24-Nov-1999

Malawi

AP/P/01/02167

24-Nov-1999

Patent Cooperation Treaty

US99/28080

24-Nov-1999

Patent Cooperation Treaty

IB99/01883

24-Nov-1999

Sierra Leone

AP/P/01/02167

00-Xxx-0000

Xxxxx Xxxxxx

2001/3845

24-Nov-1999

Sudan

AP/P/01/02167

00-Xxx-0000

Xxxxxxxxx

AP/P/01/02167

00-Xxx-0000

Xxxxxxxx, Xxxxxx Xxxxxxxx of

AP/P/01/02167

00-Xxx-0000

Xxxxxx

AP/P/01/02167

00-Xxx-0000

Xxxxxx Xxxxxx of America

09449042

00-Xxx-0000

Xxxxxx Xxxxxx of America

09519437

00-Xxx-0000

Xxxxxx Xxxxxx of America

60110127

27-Nov-1998

Zimbabwe

AP/P/01/02167

00-Xxx-0000

Xxxxxx Xxxxxx of America

60156093

24-Sep-1999

United Xxxxxx xx Xxxxxxx

00000000

00-Xxx-0000

Xxxxxx Xxxxxx of America

60177453

19-Jan-2000

ARIPO

AP/P/01/02285

23-Mar-2000

  

 
 
 

 

OAPI

OA20011000237

23-Mar-2000

Australia

2003278744

28-Aug-2003

Australia

39190/00

23-Mar-2000

Australia

2005211675

23-Sep-2005

Australia

2002244247

01-Mar-2002

Australia

2008201188

00-Xxx-0000

Xxxxxxx

00918365.8

00-Xxx-0000

Xxxxxxx

00918365.8

00-Xxx-0000

Xxxxxx

XX0000000-5

23-Mar-2000

Canada

CA2496867

28-Aug-2003

Canada

2365081

23-Mar-2000

Canada

2439687

00-Xxx-0000

Xxxxxxx Xxxxxxxx of China

00805366.9

23-Mar-2000

Peoples Republic of China

0510136279.7

00-Xxx-0000

Xxxxxx, Xxxxxxxx of

00918365.8

00-Xxx-0000

Xxxxx Xxxxxxxx

XX0000-0000

00-Xxx-0000

Xxxxxxx

EP00918365.8

23-Mar-2000

EPC

03770268.5

28-Aug-2003

EPC

10181396.2

28-Aug-2003

EPC

10181424.2

28-Aug-2003

EPC

00918365.8

23-Mar-2000

EPC

04003521.4

17-Feb-2004

EPC

02709780.7

01-Mar-2002

EPC

09172321.3

06-Oct-2009

Finland

EP00918265.8

00-Xxx-0000

Xxxxxx

00918365.8

00-Xxx-0000

Xxxxxx

AP/P/01/02285

00-Xxx-0000

Xxxxxxx

US00/07883

23-Mar-2000

Ghana

AP/P/01/02285

00-Xxx-0000

Xxxxxx

2004-01776

04-May-2004

Hong Kong

02106613.2

09-Sep-2002

Hong Kong

07102606.5

09-Mar-2007

Hungary

P0140962

00-Xxx-0000

Xxxxx

1142DELNP2005

00-Xxx-0000

Xxxxx

5999DELNP2007

28-Aug-2003

India

0100796DEL

00-Xxx-0000

Xxxxx

3702DELNP2005

22-Aug-2005

India

01432/DELNP/

09-Sep-2003

Indonesia

W00200102294

23-Mar-2000

Indonesia

W-00200702183

00-Xxx-0000

Xxxxxxx

00918365.8

00-Xxx-0000

Xxxxxx

167113

24-Feb-2005

Israel

144916

00-Xxx-0000

Xxxxx

00918365.8

00-Xxx-0000

Xxxxx

2004-569763

28-Aug-2003

Japan

2000-606618

00-Xxx-0000

Xxxxx

2002-569152

29-Aug-2003

Kenya

AP/P/01/02285

23-Mar-2000

Xxxxx, Xxxxxxxx xx

0000000/0000

00-Xxx-0000

  

 
 
 

 

Xxxxx, Xxxxxxxx of

7012156/2001

23-Mar-2000

Xxxxx, Xxxxxxxx xx

0000000/0000

00-Xxx-0000

Xxxxx, Xxxxxxxx of

7011505/2003

01-Mar-2002

Lesotho

AP/P/01/02285

00-Xxx-0000

Xxxxxxxxxx

00918365.8

23-Mar-2000

Malawi

AP/P/01/02285

00-Xxx-0000

Xxxxxx

2001009624

00-Xxx-0000

Xxxxxx

2005013921

19-Dec-2005

Monaco

00918365.8

00-Xxx-0000

Xxxxxxxxxxx

00918365.8

23-Mar-2000

New Zealand

513803

00-Xxx-0000

Xxxxxx

20014588

00-Xxx-0000

Xxxxxx

20056167

23-Dec-2005

Patent Cooperation Treaty

US03/27186

28-Aug-2003

Patent Cooperation Treaty

US00/07883

23-Mar-2000

Patent Cooperation Treaty

US02/06708

01-Mar-2002

Philippines

1200000643

00-Xxx-0000

Xxxxxxxxxxx

0-0000-000000

15-Sep-2005

Portugal

1163256

04-May-2004

Russian Federation

2001128881

23-Mar-2000

Russian Federation

2006133273

06-Sep-2006

Sierra Leone

AP/P/01/02285

23-Mar-2000

Singapore

200104916-2

00-Xxx-0000

Xxxxx Xxxxxx

2001/6980

00-Xxx-0000

Xxxxx Xxxxxx

2003/6638

00-Xxx-0000

Xxxxx

00918365.8

23-Mar-2000

Sudan

AP/P/01/02285

00-Xxx-0000

Xxxxxxxxx

AP/P/01/02285

00-Xxx-0000

Xxxxxx

00918365.8

00-Xxx-0000

Xxxxxxxxxxx

00918365.8

23-Mar-2000

Taiwan

93109651

07-Apr-2004

Taiwan

89105381

23-Mar-2000

Taiwan

93141047

09-Jun-2000

Tanzania, United Republic of

AP/P/01/02285

23-Mar-2000

Thailand

056392

22-Mar-2000

Uganda

AP/P/01/02285

00-Xxx-0000

Xxxxxx Xxxxxxx

00918365.8

00-Xxx-0000

Xxxxxx Xxxxxx of America

60398516

23-Jul-2002

United States of America

60407146

28-Aug-2002

United Xxxxxx xx Xxxxxxx

00000000

00-Xxx-0000

Xxxxxx Xxxxxx of America

10651515

28-Aug-2003

United States of America

11549580

13-Oct-2006

United Xxxxxx xx Xxxxxxx

00000000

00-Xxx-0000

Xxxxxx Xxxxxx of America

11549606

13-Oct-2006

United States of America

11549615

13-Oct-2006

United Xxxxxx xx Xxxxxxx

00000000

00-Xxx-0000

Xxxxxx Xxxxxx of America

11549875

16-Oct-2006

United Xxxxxx xx Xxxxxxx

00000000

00-Xxx-0000

Xxxxxx Xxxxxx of America

10526321

28-Feb-2005

  

 
 
 

 

United Xxxxxx xx Xxxxxxx

00000000

00-Xxx-0000

Xxxxxx Xxxxxx of America

11674126

12-Feb-2007

United Xxxxxx xx Xxxxxxx

00000000

00-Xxx-0000

Xxxxxx Xxxxxx of America

60550163

03-Mar-2004

United Xxxxxx xx Xxxxxxx

00000000

00-Xxx-0000

Xxxxxx Xxxxxx of America

60190140

16-Mar-2000

United Xxxxxx xx Xxxxxxx

00000000

00-Xxx-0000

Xxxxxx Xxxxxx of America

09535675

00-Xxx-0000

Xxxxxx Xxxxxx of America

10319356

13-Dec-2002

United Xxxxxx xx Xxxxxxx

00000000

00-Xxx-0000

Xxxxxx Xxxxxx of America

11551195

19-Oct-2006

United Xxxxxx xx Xxxxxxx

00000000

00-Xxx-0000

Xxxxxx Xxxxxx of America

12634455

09-Dec-2009

United Xxxxxx xx Xxxxxxx

00000000

00-Xxx-0000

Xxxxxx Xxxxxx of America

10602330

23-Jun-2003

United Xxxxxx xx Xxxxxxx

00000000

00-Xxx-0000

Xxxxxx Xxxxxx of America

10607035

25-Jun-2003

United States of America

10607415

25-Jun-2003

United Xxxxxx xx Xxxxxxx

00000000

00-Xxx-0000

Xxxxxx Xxxxxx of America

10876957

24-Jun-2004

United Xxxxxx xx Xxxxxxx

00000000

00-Xxx-0000

Xxxxxx Xxxxxx of America

10949694

00-Xxx-0000

Xxxxxx Xxxxxx of America

10949782

23-Sep-2004

United Xxxxxx xx Xxxxxxx

00000000

00-Xxx-0000

Xxxxxx Xxxxxx of America

10877911

24-Jun-2004

United Xxxxxx xx Xxxxxxx

00000000

00-Xxx-0000

Xxxxxx Xxxxxx of America

12571060

30-Sep-2009

United Xxxxxx xx Xxxxxxx

00000000

00-Xxx-0000

Xxxxxx Xxxxxx of America

60323016

11-Sep-2001

United Xxxxxx xx Xxxxxxx

00000000

00-Xxx-0000

Xxxxxx Xxxxxx of America

60338015

00-Xxx-0000

Xxxxxx Xxxxxx of America

60343523

20-Dec-2001

United Xxxxxx xx Xxxxxxx

00000000

00-Xxx-0000

Xxxxxx Xxxxxx of America

11696637

04-Apr-2007

United Xxxxxx xx Xxxxxxx

00000000

00-Xxx-0000

Xxxxxx Xxxxxx of America

12633721

08-Dec-2009

United Xxxxxx xx Xxxxxxx

00000000

00-Xxx-0000

Xxxxxx Xxxxxx of America

60/377570

00-Xxx-0000

Xxxxxx Xxxxxx of America

60/124087

11-Mar-1999

Viet Nam

0-0000-00000

23-Mar-2000

Zimbabwe

AP/P/01/02285

00-Xxx-0000

Xxxxxx Xxxxxx of America

09/414905

08-Oct-1999

United Xxxxxx xx Xxxxxxx

00/000000

00-Xxx-0000

Xxxxxx Xxxxxx of America

60/140028

16-Jun-1999

United Xxxxxx xx Xxxxxxx

00/000000

00-Xxx-0000

Xxxxxx Xxxxxx of America

60/254231

07-Dec-2000

United Xxxxxx xx Xxxxxxx

00/000000

00-Xxx-0000

Xxxxxx Xxxxxx of America

60/167508

01-Dec-1999

Austria

08003806.0

00-Xxx-0000

  

 
 
 

 

Xxxxxxx

08003806.0

28-Sep-2000

Canada

2386095

28-Sep-2000

Canada

2669753

28-Sep-2000

Canada

2670236

28-Sep-2000

Denmark

08003806.0

28-Sep-2000

EPC

00967114.0

28-Sep-2000

EPC

07012604.0

27-Jun-2007

EPC

08003806.0

29-Feb-2008

EPC

10181352.5

28-Sep-2000

Finland

08003806.0

00-Xxx-0000

Xxxxxx

08003806.0

28-Sep-2000

Germany

08003806.0

28-Sep-2000

Ireland

08003806.0

00-Xxx-0000

Xxxxx

08003806.0

28-Sep-2000

Luxembourg

08003806.0

28-Sep-2000

Monaco

08003806.0

00-Xxx-0000

Xxxxxxxxxxx

08003806.0

28-Sep-2000

Patent Cooperation Treaty

US00/26848

28-Sep-2000

Australia

200079880

23-Nov-2005

Australia

2005237117

00-Xxx-0000

Xxxxxxx

00970511.2

28-Sep-2000

Canada

2388939

28-Sep-2000

Germany

60040753.5-08

28-Sep-2000

EPC

00970511.2

28-Sep-2000

France

00970511.2

00-Xxx-0000

Xxxxxx Xxxxxxx

00970511.2

00-Xxx-0000

Xxxxx

2001533153

28-Sep-2000

Switzerland

00970511.2

28-Sep-2000

Patent Cooperation Xxxxxx

XX00/00000

00-Xxx-0000

Xxxxxx Xxxxxx of America

09675470

28-Sep-2000

Portugal

08003806.0

28-Sep-2000

Spain

08003806.0

28-Sep-2000

Sweden

08003806.0

28-Sep-2000

Switzerland

08003806.0

00-Xxx-0000

Xxxxxx Xxxxxxx

08003806.0

00-Xxx-0000

Xxxxxx Xxxxxx of America

60/157347

30-Sep-1999

United Xxxxxx xx Xxxxxxx

00000000

00-Xxx-0000

Xxxxxx Xxxxxx of America

09675323

28-Sep-2000

United Xxxxxx xx Xxxxxxx

00000000

00-Xxx-0000

Xxxxxx Xxxxxx of America

11835367

07-Aug-2007

United Xxxxxx xx Xxxxxxx

00000000

00-Xxx-0000

Xxxxxx Xxxxxx of America

11835397

07-Aug-2007

United Xxxxxx xx Xxxxxxx

00000000

00-Xxx-0000

Xxxxxx Xxxxxx of America

12957661

01-Dec-2010

United Xxxxxx xx Xxxxxxx

00000000

00-Xxx-0000

Xxxxxx Xxxxxx of America

60157275

00-Xxx-0000

Xxxxxx Xxxxxx of America

60236114

28-Sep-2000

United Xxxxxx xx Xxxxxxx

00000000

00-Xxx-0000

Xxxxxx Xxxxxx of America

60343452

20-Dec-2001

  

 
 
 

 

United States of America

60442496

22-Jan-2003

United Xxxxxx xx Xxxxxxx

00000000

00-Xxx-0000

Xxxxxx Xxxxxx of America

60257071

20-Dec-2000

Canada

2424581

09-Oct-2001

EPC

01979625.9

09-Oct-2001

Xxxxx

000000/00

00-Xxx-0000

Xxxxx

2008-327810

24-Dec-2008

Patent Cooperation Treaty

US01/31568

09-Oct-2001

United Xxxxxx xx Xxxxxxx

00000000

00-Xxx-0000

Xxxxxx Xxxxxx of America

60238659

06-Oct-2000

Canada

2522784

30-Mar-2004

EPC

04749530.4

31-Oct-2005

Patent Cooperation Treaty

US04/09739

00-Xxx-0000

Xxxxxx Xxxxxx of America

10814503

00-Xxx-0000

Xxxxxx Xxxxxx of America

11837508

11-Aug-2007

United States of America

11838154

13-Aug-2007

United Xxxxxx xx Xxxxxxx

00000000

00-Xxx-0000

Xxxxxx Xxxxxx of America

12406033

00-Xxx-0000

Xxxxxx Xxxxxx of America

12905778

15-Oct-2010

United Xxxxxx xx Xxxxxxx

00000000

00-Xxx-0000

Xxxxxx Xxxxxx of America

60459450

01-Apr-2003

Australia

2005330504

29-Sep-2005

Australia

2011200199

19-Jan-2011

Canada

2582231

29-Sep-2005

EPC

05857726.3

00-Xxx-0000

Xxxxx

1349KOLNP2007

00-Xxx-0000

Xxxxxx

182115

29-Sep-2005

Patent Cooperation Xxxxxx

XXXXX00/00000

00-Xxx-0000

Xxxxxx Xxxxxx of America

60609223

09-Sep-2004

United Xxxxxx xx Xxxxxxx

00000000

00-Xxx-0000

Xxxxxx Xxxxxx of America

11241670

29-Sep-2005

United Xxxxxx xx Xxxxxxx

00000000

00-Xxx-0000

Xxxxxx Xxxxxx of America

13030326

00-Xxx-0000

Xxxxxx Xxxxxx of America

60601835

12-Aug-2004

Canada

2590404

03-Oct-2005

Israel

182011

03-Oct-2005

Patent Cooperation Treaty

US2005/035786

03-Oct-2005

United States of America

60615307

01-Oct-2004

United Xxxxxx xx Xxxxxxx

00000000

00-Xxx-0000

Xxxxxx Xxxxxx of America

11241678

30-Sep-2005

United Xxxxxx xx Xxxxxxx

00000000

00-Xxx-0000

Xxxxxx Xxxxxx of America

11355561

00-Xxx-0000

Xxxxxx Xxxxxx of America

12968028

14-Dec-2010

United Xxxxxx xx Xxxxxxx

00000000

00-Xxx-0000

Xxxxxx Xxxxxx of America

13252846

04-Oct-2011

United States of America

60588195

14-Jul-2004

Australia

2007300404

23-Apr-2007

Australia

2010201023

17-Mar-2010

Canada

2649940

23-Apr-2007

  

 
 
 

 

Peoples Republic of China

2007800224496

23-Apr-2007

Eurasian Patent Organization

200802167

23-Apr-2007

EPC

07863339.3

00-Xxx-0000

Xxxxx

4253KOLNP2008

00-Xxx-0000

Xxxxxx

000000

00-Xxx-0000

Xxxxx

2009-506814

21-Oct-2008

Korea, Republic of

7028733/2008

23-Apr-2007

Patent Cooperation Treaty

US07/67235

23-Apr-2007

Singapore

200807866-9

23-Apr-2007

United Xxxxxx xx Xxxxxxx

00/000000

00-Xxx-0000

Xxxxxx Xxxxxx of America

60/825569

13-Sep-2006

United Xxxxxx xx Xxxxxxx

00/000000

00-Xxx-0000

Xxxxxx Xxxxxx of America

60/866700

00-Xxx-0000

Xxxxxx Xxxxxx of America

60/868042

00-Xxx-0000

Xxxxxx Xxxxxx of America

60/793792

22-Apr-2006

Canada

2484963

01-May-2003

EPC

03731065.3

00-Xxx-0000

Xxxxx

20040500905

01-May-2003

Patent Cooperation Treaty

US03/13477

00-Xxx-0000

Xxxxxx Xxxxxx of America

10/427280

01-May-2003

Canada

2697160

21-Aug-2008

EPC

08798419.1

21-Aug-2008

Patent Cooperation Xxxxxx

XXX/XX0000000

00-Xxx-0000

Xxxxxx Xxxxxx of America

12196271

21-Aug-2008

United Xxxxxx xx Xxxxxxx

00/000000

00-Xxx-0000

Xxxxxx Xxxxxx of America

11/941936

00-Xxx-0000

Xxxxxx Xxxxxx of America

11942689

00-Xxx-0000

Xxxxxx Xxxxxx of America

12272767

17-Nov-2008

Australia

2009212314

05-Feb-2009

Canada

2712005

00-Xxx-0000

Xxxxxxx Xxxxxxxx of China

200980104255X

05-Aug-2010

Eurasian Patent Organization

201070713/26

05-Feb-2009

EPC

09709386.8

05-Feb-2009

Hong Kong

11101901.3

25-Feb-2011

Israel

207378

03-Aug-2010

Japan

0000000000

00-Xxx-0000

Xxxxx, Xxxxxxxx of

1020107019161

05-Feb-2009

Patent Cooperation Treaty

US2009/033280

05-Feb-2009

Singapore

20105723-0

04-Aug-2010

United States of America

61093694

02-Sep-2008

United Xxxxxx xx Xxxxxxx

00000000

00-Xxx-0000

Xxxxxx Xxxxxx of America

61/026472

05-Feb-2008

Australia

2009231589

03-Apr-2009

Canada

2728889

03-Apr-2009

Peoples Republic of China

2009801121621

30-Sep-2010

EPC

09726748.8

03-Apr-2009

Hong Kong

11112286.5

00-Xxx-0000

Xxxxx

2011503236

00-Xxx-0000

Xxxxx, Xxxxxxxx of

1020107024458

03-Apr-2009

  

 
 
 

 

Patent Cooperation Treaty

XX0000000

03-Apr-2009

United Xxxxxx xx Xxxxxxx

00/000000

00-Xxx-0000

Xxxxxx Xxxxxx of America

61042240

03-Apr-2008

Australia

2009256009

05-Jun-2009

Canada

2724130

05-Jun-2009

Peoples Republic of China

200980119770

29-Nov-2010

EPC

09759550.8

05-Jun-2009

Hong Kong

11105425.1

00-Xxx-0000

Xxxxx

5019KOLNP2010

29-Dec-2010

Israel

209693

05-Jun-2009

Japan

2011512712

29-Nov-2010

Patent Cooperation Treaty

US0000000000

05-Jun-2009

United States of America

12479626

05-Jun-2009

United Xxxxxx xx Xxxxxxx

00000000

00-Xxx-0000

Xxxxxx Xxxxxx of America

61104083

09-Oct-2008

Patent Cooperation Treaty

US09058260

00-Xxx-0000

Xxxxxx Xxxxxx of America

61100246

25-Sep-2008

United Xxxxxx xx Xxxxxxx

00000000

00-Xxx-0000

Xxxxxx Xxxxxx of America

61184283

04-Jun-2009

United States of America

61186360

11-Jun-2009

United Xxxxxx xx Xxxxxxx

00000000

00-Xxx-0000

Xxxxxx Xxxxxx of America

61099880

24-Sep-2008

Patent Cooperation Treaty

US1165298

15-Dec-2011

United Xxxxxx xx Xxxxxxx

00000000

00-Xxx-0000

Xxxxxx Xxxxxx of America

61/262076

00-Xxx-0000

Xxxxxx Xxxxxx of America

61423457

15-Dec-2010

United States of America

61154715

23-Feb-2009

Patent Cooperation Treaty

US1165552

00-Xxx-0000

Xxxxxx Xxxxxx of America

61/262101

00-Xxx-0000

Xxxxxx Xxxxxx of America

61424173

17-Dec-2010

United States of America

13328760

16-Dec-2011

United Xxxxxx xx Xxxxxxx

00000000

00-Xxx-0000

Xxxxxx Xxxxxx of America

61261721

16-Nov-2009

Patent Cooperation Treaty

US11065482

16-Dec-2011

United States of America

13328374

16-Dec-2011

United Xxxxxx xx Xxxxxxx

00000000

00-Xxx-0000

Xxxxxx Xxxxxx of America

61424156

17-Dec-2010

Patent Cooperation Xxxxxx

XX00/00000

00-Xxx-0000

Xxxxxx Xxxxxx of America

61266092

02-Dec-2009

United Xxxxxx xx Xxxxxxx

00000000

00-Xxx-0000

Xxxxxx Xxxxxx of America

61266416

03-Dec-2009

United States of America

61266483

03-Dec-2009

United Xxxxxx xx Xxxxxxx

00000000

00-Xxx-0000

Xxxxxx Xxxxxx of America

61265294

00-Xxx-0000

Xxxxxx Xxxxxx of America

12731692

25-Mar-2010

United Xxxxxx xx Xxxxxxx

00000000

00-Xxx-0000

Xxxxxx Xxxxxx of America

61506517

11-Jul-2011

United States of America

61493267

03-Jun-2011

United Xxxxxx xx Xxxxxxx

00000000

00-Xxx-0000

Xxxxxx Xxxxxx of America

61495305

09-Jun-2011

 

 
 
 

 

SCHEDULE C

 

SELLER TRADEMARK RIGHTS

 

Country/region

Serial No.

Filing date

United Xxxxxx xx Xxxxxxx

00000000

00-Xxx-0000

Xxxxxx Xxxxxx of America

77283286

19-Sep-2007

United Xxxxxx xx Xxxxxxx

00000000

00-Xxx-0000

Xxxxxx Xxxxxx of America

77938189

17-Feb-2010

United Xxxxxx xx Xxxxxxx

00000000

00-Xxx-0000

Xxxxxx Xxxxxx of America

77938239

00-Xxx-0000

Xxxxxx Xxxxxx xx Xxxxxxx

00000000

00-Xxx-0000

Xxxxxx Xxxxxx of America

76255928

11-May-2001

United Xxxxxx xx Xxxxxxx

00000000

00-Xxx-0000

Xxxxxx Xxxxxx of America

75799566

14-Sep-1999

United Xxxxxx xx Xxxxxxx

00000000

00-Xxx-0000

Xxxxxx Xxxxxx of America

75799567

14-Sep-1999

United Xxxxxx xx Xxxxxxx

00000000

00-Xxx-0000

Xxxxxx Xxxxxx of America

74584447

12-Oct-1994

United Xxxxxx xx Xxxxxxx

00000000

00-Xxx-0000

Xxxxxx Xxxxxx of America

75799574

21-Sep-1999

EPC

002336261

10-Aug-2001

United Xxxxxx xx Xxxxxxx

00000000

00-Xxx-0000

Xxxxxx Xxxxxx of America

76252169

09-May-2001

United Xxxxxx xx Xxxxxxx

00000000

00-Xxx-0000

Xxxxxx Xxxxxx of America

78906864

13-Jun-2006

United Xxxxxx xx Xxxxxxx

00000000

00-Xxx-0000

Xxxxxx Xxxxxx of America

78231954

00-Xxx-0000

Xxxxxx Xxxxxx of America

77283286

19-Sep-2007

United Xxxxxx xx Xxxxxxx

00000000

00-Xxx-0000

Xxxxxx Xxxxxx of America

77938189

17-Feb-2010

United Xxxxxx xx Xxxxxxx

00000000

00-Xxx-0000

Xxxxxx Xxxxxx of America

77938239

17-Feb-2010

 

 
 
 

 

SCHEDULE 3.5

 

KEY ASSETS

 

 

Patent family base docket No.: 208.3: NE3107 (17a-ethynyl-5-androstene-3b, 7b, 17b-triol) compound, formulations, first medical use

Country

Serial #

Filing Date

Publication #

Patent #

Issue Date

Expiration Date

US

11/835,334

8-7-2007

  

7776845

8-17-2010

9-28-2020

WO*

PCT/00/26848

9-28-2000

WO0123405

      

CH

08003806.0

9-28-2000

  

1955700

3-16-2011

9-28-2020

DE

08003806.0

9-28-2000

  

1955700

3-16-2011

9-28-2020

ES

08003806.0

9-28-2000

  

1955700

3-16-2011

9-28-2020

FR

08003806.0

9-28-2000

  

1955700

3-16-2011

9-28-2020

GB

08003806.0

9-28-2000

  

1955700

3-16-2011

9-28-2020

IT

08003806.0

9-28-2000

  

1955700

3-16-2011

9-28-2020

NL

08003806.0

9-28-2000

  

1955700

3-16-2011

9-28-2020

CA

2669753

9-28-2000

  

2669753

6-26-2012

9-28-2020

             

 

* This WO/PCT application has expired and has been converted to national and/or regional patent applications. It is included in the Key Asset List only to show the patent family and to facilitate the processing and recording of any formalities with the WIPO such as but not limited to assignments, owner’s name and address changes and related filings.

  

 
 
 

 

Patent family - base docket Nos.: 323.6, 334, 335: NE3107 clinical uses (inflammation treatment), screening methods

Country

Serial #

Filing Date

Publication #

Patent #

Issue Date

Expiration Date

US

11941936

11-17-2007

20080153797

8354396

1-15-2013

7-7-2031

US

11942664

11-19-2007

20080146532

8217025

7-10-2012

1-30-2031

WO*

PCT/US07/67235

4-23-2007

WO2008/039566

      

AU

2007300404

4-23-2007

  

2007300404

5-27-2010

4-23-2027

AU

2010201023

4-23-2007

  

2010201023

5-24-2012

4-23-2027

EP (payment made in BE, CH, DE, DK, ES, FR, GB, HU, IE, IT, LU, NL, PL, SE)

07863339.3

4-23-2007

2012773

2012773

6-20-2012

4-23-2027

CA

2649940

4-23-2007

2649940

2649940

8-7-2012

4-23-2027

JP

2009506814

4-23-2007

  

5130591

11-16-2012

4-23-2027

SG

200807866-9

4-23-2007

2008039566

147151

5-31-2011

4-23-2027

             

 

 
 
 

 

Patent family - base docket Nos.: 340.1: NE3107 solid state forms, formulations, synthesis methods

Country

Serial #

Filing Date

Publication #

Patent #

Issue Date

Expiration Date

US

12418559

4-3-2009

20090291933

8252947

8-28-2012

4-18-2030

US

14459493

8-14-2014

        

US

14459528

8-14-2014

        

WO*

PCT/US09/39567

4-3-2009

WO2009/124300

      

AU

2009231589

4-3-2009

  

2009231589

2-20-2014

4-3-2029

CA

2728889

4-3-2009

        

EP

09726748.8

4-3-2009

2273994

      

KR

1020107024458

4-3-2009

        

JP

2011-503236

4-3-2009

2011-527986

      

 

* This WO/PCT application has expired and has been converted to national and/or regional patent applications. It is included in the Key Asset List only to show the patent family and to facilitate the processing and recording of any formalities with the WIPO such as but not limited to assignments, owner’s name and address changes and related filings.

  

 
 
 

 

Patent family - base docket Nos.: 342.1 - NE3107 commercial scale synthesis methods

Country

Serial #

Filing Date

Publication #

Patent #

Issue Date

Expiration Date

US

12479626

6-5-2009

20090326251

8309746

11-13-2012

11-2-2030

US

13664304

10-30-2012

2013066087

      

WO*

PCT/US09/046477

6-5-2009

WO2009/149392

      

AU

2009256009

6-5-2009

        

CA

2724130

6-5-2009

        

EP

09759550.8

6-5-2009

2300489

      

JP

2011-512712

6-5-2009

2011-522836

      

 

* This WO/PCT application has expired and has been converted to national and/or regional patent applications. It is included in the Key Asset List only to show the patent family and to facilitate the processing and recording of any formalities with the WIPO such as but not limited to assignments, owner’s name and address changes and related filings.

  

 
 
 

 

EXHIBIT A

 

FORM OF INTELLECTUAL PROPERTY TRANSFER AND ASSIGNMENT AGREEMENT

 

 

INTELLECTUAL PROPERTY TRANSFER AND ASSIGNMENT AGREEMENT

 

This Intellectual Property Transfer and Assignment Agreement (“IP Transfer and Assignment”), dated as of December 9, 2014, is made by Harbor Therapeutics, Inc., a Delaware corporation (“Seller”), in favor of Reserva, LLC (“Buyer”), the purchaser of certain assets of Seller pursuant to an Asset Purchase Agreement by and among Seller, Harbor Diversified, Inc., a Delaware corporation (“Parent”), and Buyer, dated as of December 9, 2014 (the “Asset Purchase Agreement”).

 

R E C I T A L S

 

WHEREAS, under the terms of the Asset Purchase Agreement, Seller has conveyed, transferred and assigned to Buyer, among other assets, certain intellectual property of Seller, and has agreed to execute and deliver this IP Transfer and Assignment, for recording with the United States Patent and Trademark Office and corresponding entities or agencies in any applicable jurisdictions; and

 

NOW THEREFORE, the parties agree as follows:

 

I.       Assignment. For good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, Seller hereby irrevocably conveys, transfers and assigns to Buyer, and Buyer hereby accepts, all of Seller’s right, title and interest in and to the following (the “Assigned IP”):

 

A.     the patents and patent applications listed on Schedule A hereto, and any future patents that claim priority from or the benefit of the filing date of any of the patents listed on Schedule A, and including any and all extensions, supplementary protection certificates and the like with respect to any of the foregoing (the “Patents”);

 

B.     issued, pending and abandoned U.S. and foreign trademarks and trademark applications set forth on Schedule B hereto (the “Trademarks”); and

 

C.     all rights of any kind whatsoever of Seller accruing under any of the foregoing provided by applicable law of any jurisdiction, by international treaties and conventions and otherwise throughout the world.

 

II.       Recordation and Further Actions. Seller hereby authorizes the Commissioner for Patents and the Commissioner for Trademarks in the United States Patent and Trademark Office and the officials of corresponding entities or agencies in any applicable jurisdictions to record and register this IP Transfer and Assignment upon request by Buyer. Following the date hereof, upon Buyer’s reasonable request and at Buyer’s sole cost and expense, Seller shall take such steps and actions, and provide such cooperation and assistance to Buyer and its successors, assigns and legal representatives as may be reasonably necessary to effect the assignment of the Assigned IP to Buyer, or any assignee or successor thereto.

 

III.       Disclaimer of Representations and Warrants; Terms of the Asset Purchase Agreement. Seller, Parent and Buyer acknowledge and agree that no representations or warranties are made in this IP Transfer and Assignment. Seller, Parent and Buyer acknowledge and agree that this IP Transfer and Assignment is entered into pursuant to the Asset Purchase Agreement, to which reference is made for the exclusive statement of the rights and obligations of Seller, Parent and Buyer with respect to the Assigned IP. Any and all representations, warranties, covenants, agreements, indemnities and limitations of liability relating to the Assigned IP are contained solely in the Asset Purchase Agreement.

 

 

 
1
 

 

 

IV.     Counterparts. This IP Transfer and Assignment may be executed in counterparts, each of which shall be deemed an original, but all of which together shall be deemed to be one and the same agreement. A signed copy of this IP Transfer and Assignment delivered by facsimile, e-mail or other means of electronic transmission shall be deemed to have the same legal effect as delivery of an original signed copy of this IP Transfer and Assignment.

 

V.     Successors and Assigns. This IP Transfer and Assignment shall be binding upon and shall inure to the benefit of the parties hereto and their respective successors and assigns.

 

VI.     Governing Law. This IP Transfer and Assignment and any claim, controversy, dispute or cause of action (whether in contract, tort or otherwise) based upon, arising out of or relating to this IP Transfer and Assignment and the transactions contemplated hereby shall be governed by, and construed in accordance with, the laws of the United States and the State of New York, without giving effect to any choice or conflict of law provision or rule (whether of the State of New York or any other jurisdiction).

 

 

[Signature Page Follows]

 

 

 
2
 

 

 

IN WITNESS WHEREOF, Seller has duly executed and delivered this IP Transfer and Assignment as of the date first above written.

 

 

Harbor Therapeutics, Inc.

 

 

 

 

 

 

 

By:

/s/ Xxxxxxxxx Xxxxx  

 

 

 

 

Name: Xxxxxxxxx Xxxxx

Title: Chairman  

     
     
  Harbor Diversified, Inc.
     
     
  By: /s/ Xxxxxxxxx Xxxxx  
     
 

Name: Xxxxxxxxx Xxxxx

Title: Chairman

     
     
  AGREED TO AND ACCEPTED:
     
  Reserva, LLC
     
     
  By:
     
 

Name: Xxxxxx Xxxxxx

Title: Chairman & Managing Member

 

 

3
 
 

 

  

SChedule A

 

Assigned Patents and Patent Applications

 

U.S. Patent Office Customer No. 26551

Patent applications and issued patents

 

Application

Patent No.

Publication No.

Attorney Docket No.

Filing or 371(c) Date

PCT/US13/70754

-

-

354.2 WO

11-19-2013

PCT/US00/26848

-

-

  

09-28-2000

PCT/US13/50768

-

-

353.2 WO

07-16-2013

PCT/US11/65552

-

-

348.2 WO

12-16-2011

PCT/US11/65482

-

-

350.1 WO

12-16-2011

PCT/US11/65298

-

-

346.1 WO

12-15-2011

PCT/US10/58449

-

-

351.5 WO

11-30-2010

PCT/US09/58260

-

-

345.5 WO

09-24-2009

PCT/US09/46477

-

-

342.1 WO

06-05-2009

PCT/US09/39567

-

-

340.1 WO

04-03-2009

PCT/US09/33280

-

-

338.2 WO

02-05-2009

PCT/US08/73933

-

-

333.1WO

08-21-2008

PCT/US07/67235

-

-

323.6 WO

04-23-2007

PCT/US05/35786

-

-

318.3 WO

10-03-2005

PCT/US05/35020

-

-

314.3 WO

09-29-2005

PCT/US04/09739

-

-

302.1 WO

03-30-2004

61/775,086

-

-

354.1P

03-08-2013

61/684,140

-

-

359P

08-17-2012

61/672,162

-

-

353P

07-16-2012

61/668,294

-

-

358P

07-05-2012

61/506,517

-

-

354P

07-11-2011

61/495,891

-

-

356.1P

06-10-2011

61/495,305

-

-

356P

06-09-2011

61/493,267

-

-

355P

06-03-2011

61/424,173

-

-

348.1RP

12-17-2010

61/424,156

-

-

350RP

12-17-2010

61/423,457

-

-

346RP

12-15-2010

61/266,483

-

-

351.4P

12-03-2009

61/266,416

-

-

351.3P

12-03-2009

61/266,291

-

-

351.2P

12-03-2009

61/266,092

-

-

351.1P

12-02-2009

 

 

 
Schedule A-1
 

 

 

61/265,294

-

-

351P

11-30-2009

61/262,133

-

-

350P

11-17-2009

61/262,101

-

-

348.1P

11-17-2009

61/262,092

-

-

348P

11-17-2009

61/262,076

-

-

346P

11-17-2009

61/261,721

-

-

349P

11-16-2009

61/186,360

-

-

345.4P

06-11-2009

61/184,283

-

-

345.3P

06-04-2009

61/162,620

-

-

345.2P

03-23-2009

61/154,715

-

-

347P

02-23-2009

61/104,083

-

-

344P

10-09-2008

61/100,246

-

-

345.1P

09-25-2008

61/099,880

-

-

345P

09-24-2008

61/093,694

-

-

338.1P

09-02-2008

61/059,714

-

-

341P

06-06-2008

61/059,658

-

-

342P

06-06-2008

61/042,240

-

-

340P

04-03-2008

61/039,902

-

-

339P

03-27-2008

61/026,472

-

-

338 P

02-05-2008

61/026,467

-

-

337P

02-05-2008

60/965,730

-

-

333P

08-21-2007

60/891,222

-

-

328.1P

02-22-2007

60/888,058

-

-

330.1P

02-02-2007

60/885,003

-

-

329.1P

01-15-2007

60/868,042

-

-

323.5P

11-30-2006

60/866,700

-

-

323.4P

11-21-2006

60/866,395

-

-

330P

11-17-2006

60/843,112

-

-

323.1P

09-08-2006

60/829,848

-

-

329P

10-17-2006

60/825,569

-

-

323.2P

09-13-2006

60/825,564

-

-

323.3P

09-13-2006

60/825,389

-

-

328P

09-12-2006

60/821,096

-

-

322.1P

08-01-2006

60/820,700

-

-

324P

07-28-2006

60/793,792

-

-

323P

04-22-2006

60/760,791

-

-

322 P

01-19-2006

60/681,611

-

-

317RP

05-16-2005

60/628,252

-

-

318-2P

11-15-2004

60/615,307

-

-

318.1P

10-01-2004

 

 

 
Schedule A-2
 

 

 

60/614,869

-

-

314.2P

09-29-2004

60/609,223

-

-

314.1P

09-09-2004

60/601,835

-

-

314P

08-12-2004

60/588,195

-

-

318P

07-14-2004

60/572,451

-

-

317P

05-18-2004

60/552,452

-

-

202.16P

03-10-2004

60/550,163

-

-

202.15P

03-03-2004

60/479,257

-

-

202.12P

06-17-2003

60/443,282

-

-

281P2

01-27-2003

60/442,496

-

-

256.2P

01-22-2003

60/408,332

-

-

288P

09-04-2002

60/408,287

-

-

289P

09-04-2002

60/407,146

-

-

202.11P

08-28-2002

60/398,516

-

-

202.10P

07-23-2002

60/377,570

-

-

202.9P

05-01-2002

60/351,866

-

-

281P

01-25-2002

60/343,523

-

-

202.7P

12-20-2001

60/343,452

-

-

256.1P

12-20-2001

60/340,054

-

-

202.5P

11-01-2001

60/338,015

-

-

202.6P

11-08-2001

60/328,738

-

-

271P

10-11-2001

60/326,126

-

-

207.4P

09-26-2001

60/323,016

-

-

202.4P

09-11-2001

60/314,704

-

-

258.6P

08-24-2001

60/272,624

-

-

246 P

03-01-2001

60/271,704

-

-

268P

02-26-2001

60/236,920

-

-

256 P

09-28-2000

60/236,919

-

-

255 P

09-28-2000

60/236,114

-

-

254 P

09-28-2000

60/209,405

-

-

216.1P

06-01-2000

60/209,403

-

-

218.1P

06-01-2000

60/190,140

-

-

202.1AP

03-16-2000

60/177,453

-

-

165 P

01-19-2000

60/167,508

-

-

207 P

12-01-1999

60/167,495

-

-

207.2P

12-01-1999

60/166,116

-

-

208.2P

11-16-1999

60/161,453

-

-

214 P

10-25-1999

60/157,347

-

-

208.1P

09-30-1999

60/157,275

-

-

208P

09-30-1999

 

 

 
Schedule A-3
 

 

 

60/153,217

-

-

215 P

09-13-1999

60/145,823

-

-

216 P

07-27-1999

60/142,386

-

-

217 P

07-06-1999

60/137,745

-

-

218 P

06-03-1999

60/124,087

-

-

202 P

03-11-1999

60/114,145

-

-

219 P

12-24-1998

60/112,206

-

-

220.P2

12-15-1998

60/110,127

-

-

159 P

11-27-1998

60/109,924

-

-

158 P

11-24-1998

60/109,923

-

-

157 P

11-24-1998

60/107,138

-

-

221 P

11-05-1998

60/095,039

-

-

223.P3

08-03-1998

60/076,662

-

-

223.P2

03-03-1998

60/076,481

-

-

223 P

03-02-1998

60/069,850

-

-

220 P

12-17-1997

60/015,695

-

-

153 P

04-17-1996

14/459,528

-

-

340.1CR

08-14-2014

14/459,493

-

-

340.1DR

08-14-2014

14/027,842

-

US 2014-0018337 A1

202.13C6.1D

09-16-2013

14/027,825

-

US 2014-0018336 A1

202.13C6.1C

09-16-2013

13/943,743

-

-

353.2

07-16-2013

13/919,728

-

US 2013-0338125 A1

338.2D3

06-17-2013

13/919,593

-

US 2013-0345455 A1

338.2D2

06-17-2013

13/919,386

-

US 2013-0345184 A1

338.2D

06-17-2013

13/835,995

-

US 2014-0010806 A1

358.1

03-15-2013

13/734,147

-

US 2013-0164780 A1

335D

01-04-2013

13/664,304

-

US 2013-0066087 A1

342.1D

10-30-2012

13/563,996

-

US 2012-0302537 A1

340.1D

08-01-2012

13/563,982

-

US 2012-0296105 A1

340.1C

08-01-2012

13/328,760

-

US 2012-0252774 A1

348.2

12-16-2011

13/328,374

-

US 2012-0220560 A1

350.1

12-16-2011

13/327,701

-

US 2012-0214987 A1

346.1

12-15-2011

13/306,141

8,367,646

US 2012-0071454 A1

208.3C6C

11-29-2011

13/252,846

-

US 2012-0029260 A1

318.6C

10-04-2011

13/183,275

8,541,600

US 2012-0041016 A1

202.3CC2

07-14-2011

13/107,573

-

US 2011-0218162 A1

202.8DC2

05-13-2011

13/095,528

8,569,275

US 2011-0212935 A1

202.13C6.1

04-27-2011

13/030,326

8,586,770

US 2011-0137057 A1

314.4C

02-18-2011

12/968,028

-

US 2011-0085984 A1

318.5C

12-14-2010

 

 

 
Schedule A-4
 

 

 

12/957,661

8,076,316

US 2011-0098260 A1

208.3C6

12-01-2010

12/957,273

-

US 2011-0129423 A1

351.5

11-30-2010

12/905,778

-

US 2011-0028711 A1

302.1C5

10-15-2010

12/792,942

7,906,497

US 2010-0240633 A1

208.3C5

06-03-2010

12/732,164

-

US 2010-0227841 A1

352.1

03-25-2010

12/731,692

-

US 2010-0222315 A1

352

03-25-2010

12/634,455

8,106,036

US 2010-0222313 A1

202.2CC3C1

12-09-2009

12/633,721

7,947,846

US 2010-0222425 A1

202.8DC

12-08-2009

12/571,060

8,022,234

US 2011-0009372 A1

202.3CC

09-30-2009

12/566,565

-

US 2010-0075937 A1

345.5

09-24-2009

12/479,626

8,309,746

US 2009-0326251 A1

342.1

06-05-2009

12/418,559

8,252,947

US 2009-0291933 A1

340.1

04-03-2009

12/406,033

7,842,680

US 2009-0181936 A1

302.1C4

03-17-2009

12/405,970

7,638,509

US 2009-0176752 A1

302.1C3

03-17-2009

12/370,510

8,518,922

US 2009-0291932 A1

338.2

02-12-2009

12/272,767

8,486,926

US 2009-0143349 A1

335.2

11-17-2008

12/196,271

-

US 2009-0258850 A1

333.1

08-21-2008

11/942,689

-

US 2008-0153792 A1

335.1

11-19-2007

11/942,664

8,217,025

US 2008-0146532 A1

334.1

11-19-2007

11/941,936

8,354,396

US 2008-0153797 A1

335

11-17-2007

11/941,934

-

US 2008-0221074 A1

334

11-17-2007

11/862,153

7,550,450

US 2008-0070881 A1

302.1D

09-26-2007

11/838,154

7,514,420

US 2008-0004250 A1

302.1C2

08-13-2007

11/837,508

7,462,610

US 2008-0009472 A1

302.1C

08-11-2007

11/835,397

7,863,261

US 2008-0176823 A1

208.3C4

08-07-2007

11/835,394

7,696,189

-

208.3C3

08-07-2007

11/835,367

7,691,835

US 2008-0058301 A1

208.3C2

08-07-2007

11/835,334

7,776,845

US 2008-0021006 A1

208.3C

08-07-2007

11/696,637

-

US 2008-0015174 A1

202.8.1

04-04-2007

11/674,128

7,547,687

US 2007-0275938 A1

202.14C2

02-12-2007

11/674,126

7,482,334

US 2007-0275937 A1

202.14C

02-12-2007

11/564,026

-

US 2007-0275936 A1

202.3C2

11-28-2006

11/552,095

7,723,532

US 2008-0176824 A1

202.2CC3

10-23-2006

11/551,202

-

US 2008-0045490 A1

202.2CC

10-19-2006

11/551,195

-

US 2009-0215737 A1

202.2CC2

10-19-2006

11/549,875

7,935,839

US 2007-0213309 A1

202.13C6

10-16-2006

11/549,825

-

US 2007-0265236 A1

202.13C5

10-16-2006

11/549,615

-

US 2008-0085873 A1

202.13C4

10-13-2006

11/549,606

-

US 2007-0203107 A1

202.13C3

10-13-2006

 

 

 
Schedule A-5
 

 

 

11/549,580

7,910,571

US 2008-0090791 A1

202.13C

10-13-2006

11/389,319

-

US 2007-0077203 A1

318.6

03-24-2006

11/389,294

7,910,755

US 2007-0077201 A1

314.4

03-25-2006

11/355,561

-

US 2007-0053832 A1

318.5

02-15-2006

11/242,547

-

US 2006-0088473 A1

318.4

10-03-2005

11/241,678

-

US 2006-0073099 A1

318.3

09-30-2005

11/241,670

-

US 2007-0014719 A1

314.3

09-29-2005

11/234,675

-

US 2006-0079492 A1

202.8D

09-23-2005

10/949,782

-

US 2005-0075321 A1

202.2DC4

09-23-2004

10/949,694

-

US 2005-0256095 A1

202.2DC3

09-23-2004

10/890,490

-

US 2005-0159366 A1

202.2DC2

07-13-2004

10/877,911

-

US 2007-0129282 A1

202.3C

06-24-2004

10/876,957

-

US 2005-0282732 A1

202.2DC

06-24-2004

10/814,503

-

US 2004-0242618 A1

302.1

03-30-2004

10/741,929

-

US 2004-0220161 A1

202.2D6

12-19-2003

10/728,400

-

US 2005-0101581 A1

202.14

12-05-2003

10/651,515

-

US 2004-0138187 A1

202.13

08-28-2003

10/607,415

7,524,835

US 2006-0063749 A1

202.2D5

06-25-2003

10/607,035

-

US 2004-0097406 A1

202.2D4

06-25-2003

10/606,524

-

-

202.2D3

06-25-2003

10/602,330

-

US 2004-0220114 A1

202.2D2

06-23-2003

10/526,321

-

-

202.13 US

-

10/329,065

-

US 2004-0116359 A1

202.2D

12-21-2002

10/319,356

7,396,827

US 2004-0043973 A1

202.2C

12-13-2002

10/087,929

-

US 2003-0083231 A1

202.8

03-01-2002

09/820,483

-

US 2003-0060425 A1

202.3

03-29-2001

09/675,470

-

-

214.2

09-28-2000

09/675,323

-

-

208.3

09-28-2000

09/672,687

-

-

257

09-28-2000

09/586,673

-

-

216.1

06-01-2000

09/586,672

-

-

218.1

06-01-2000

09/535,675

6,667,299

-

202.2

03-23-2000

09/519,437

-

-

159.1A

03-03-2000

09/518,986

-

-

157.1A

03-03-2000

09/518,779

-

-

158.1A

03-03-2000

09/461,026

-

-

220

12-15-1999

09/449,184

-

-

158.1

11-24-1999

09/449,042

-

-

159.1

11-24-1999

09/449,004

-

-

157.1

11-24-1999

09/423,467

6,384,251

-

231

11-08-1999

09/174,601

-

-

153.2

10-19-1998

08/327,843

5,424,463

-

240.C4

10-24-1994

08/123,151

-

-

240.C2

09-02-1993

07/575,156

-

-

240

08-29-1990

07/182,480

4,956,355

-

150.2

04-15-1988

07/090,637

-

-

150.1

08-27-1987

 

 

 
Schedule A-6
 

 

 

Worldwide patent filings

Country

Application Number

Filing Date

Australia

25741/97

17-Apr-1997

Canada

2251733

17-Apr-1997

Peoples Republic of China

97193912.8

17-Apr-1997

EPC

97917365.5

17-Apr-1997

Hong Kong

99105169.6

00-Xxx-0000

Xxxxxx

126623

00-Xxx-0000

Xxxxx, Xxxxxxxx of

708339/1998

17-Apr-1997

Norway

19984851

17-Apr-1997

Patent Cooperation Treaty

IB97/00414

17-Apr-1997

Patent Cooperation Treaty

EP97/05716

16-Oct-1997

United Xxxxxx xx Xxxxxxx

00000000

00-Xxx-0000

Xxxxxx Xxxxxx of America

60015695

17-Apr-1996

ARIPO

AP/P/01/02182

24-Nov-1999

OAPI

OA20011000127

24-Nov-1999

Australia

17453/00

24-Nov-1999

Australia

2004237812

00-Xxx-0000

Xxxxxxx

99960591.8

00-Xxx-0000

Xxxxxxx

99960591.8

00-Xxx-0000

Xxxxxx

PI9915623-7

24-Nov-1999

Canada

2356539

00-Xxx-0000

Xxxxxxx Xxxxxxxx of China

99813696.4

00-Xxx-0000

Xxxxxx, Xxxxxxxx of

99960591.8

00-Xxx-0000

Xxxxxxx

99960591.8

24-Nov-1999

EPC

99960591.8

00-Xxx-0000

Xxxxxxx

99960591.8

00-Xxx-0000

Xxxxxx

99960591.8

00-Xxx-0000

Xxxxxxx

99960591.8

00-Xxx-0000

Xxxxxx

99960591.8

24-Nov-1999

Hong Kong

02105184.3

12-Jul-2002

Indonesia

W-00200101128

00-Xxx-0000

Xxxxxxxxx

W-00200801236

24-Nov-1999

Ireland

99960591.8

00-Xxx-0000

Xxxxxx

142941

00-Xxx-0000

Xxxxx

99960591.8

00-Xxx-0000

Xxxxx

2000-584896

00-Xxx-0000

Xxxxx, Xxxxxxxx of

7006523/2001

00-Xxx-0000

 

 

 
Xxxxxxxx X-0
 

 

 

Xxxxx, Xxxxxxxx of

7026568/2006

15-Dec-2006

Luxembourg

99960591.8

00-Xxx-0000

Xxxxxx

a/2001/005166

24-Nov-1999

Monaco

99960591.8

00-Xxx-0000

Xxxxxxxxxxx

99960591.8

24-Nov-1999

New Zealand

511720

24-Nov-1999

Patent Cooperation Treaty

US99/28079

24-Nov-1999

Patent Cooperation Treaty

IB99/01879

24-Nov-1999

Portugal

99960591.8

00-Xxx-0000

Xxxxxxxxx

200102430-6

00-Xxx-0000

Xxxxx Xxxxxx

2001/3852

00-Xxx-0000

Xxxxx

99960591.8

00-Xxx-0000

Xxxxxx

99960591.8

00-Xxx-0000

Xxxxxxxxxxx

99960591.8

00-Xxx-0000

Xxxxxx Xxxxxxx

99960591.8

00-Xxx-0000

Xxxxxx Xxxxxx of America

09449004

00-Xxx-0000

Xxxxxx Xxxxxx of America

09518986

00-Xxx-0000

Xxxxxx Xxxxxx of America

60109923

24-Nov-1998

ARIPO

AP/P/01/02181

24-Nov-1999

OAPI

OA20011000128

24-Nov-1999

Australia

00000/00

00-Xxx-0000

Xxxxxxx

99965050.0

00-Xxx-0000

Xxxxxxx

99965050.0

00-Xxx-0000

Xxxxxx

PI9915644-0

24-Nov-1999

Canada

2352205

00-Xxx-0000

Xxxxxxx Xxxxxxxx of China

99813658.1

00-Xxx-0000

Xxxxxx, Xxxxxxxx of

99965050.0

00-Xxx-0000

Xxxxxxx

99965050.0

24-Nov-1999

EPC

99965050.0

00-Xxx-0000

Xxxxxxx

99965050.0

00-Xxx-0000

Xxxxxx

99965050.0

00-Xxx-0000

Xxxxxx

AP/P/01/02181

00-Xxx-0000

Xxxxxxx

99965050.0

24-Nov-1999

Ghana

AP/P/01/02181

00-Xxx-0000

Xxxxxx

99965050.0

24-Nov-1999

Hong Kong

02102267.0

25-Mar-2002

Indonesia

W-00200101129

24-Nov-1999

Ireland

99965050.0

00-Xxx-0000

Xxxxxx

142942

00-Xxx-0000

Xxxxx

99965050.0

00-Xxx-0000

Xxxxx

2000584873

00-Xxx-0000

Xxxxx

AP/P/01/02181

00-Xxx-0000

Xxxxx, Xxxxxxxx of

7006525/2001

24-May-2001

Lesotho

AP/P/01/02181

00-Xxx-0000

Xxxxxxxxxx

99965050.0

24-Nov-1999

Malawi

AP/P/01/02181

00-Xxx-0000

Xxxxxx

a/2001/005170

24-Nov-1999

Monaco

99965050.0

00-Xxx-0000

Xxxxxxxxxxx

99965050.0

24-Nov-1999

 

 

 
Schedule X-0
 

 

 

Xxx Xxxxxxx

000000

24-Nov-1999

Patent Cooperation Treaty

US99/28082

24-Nov-1999

Patent Cooperation Treaty

IB99/01877

24-Nov-1999

Portugal

99965050.0

00-Xxx-0000

Xxxxxx Xxxxx

XX/X/00/00000

00-Xxx-0000

Xxxxxxxxx

200102440-5

00-Xxx-0000

Xxxxx Xxxxxx

2001/3847

00-Xxx-0000

Xxxxx

99965050.0

24-Nov-1999

Sudan

AP/P/01/02181

00-Xxx-0000

Xxxxxxxxx

AP/P/01/02181

00-Xxx-0000

Xxxxxx

99965050.0

00-Xxx-0000

Xxxxxxxxxxx

99965050.0

00-Xxx-0000

Xxxxxxxx, Xxxxxx Xxxxxxxx of

AP/P/01/02181

00-Xxx-0000

Xxxxxx

AP/P/01/02181

00-Xxx-0000

Xxxxxx Xxxxxxx

99965050.0

00-Xxx-0000

Xxxxxx Xxxxxx of America

09449184

00-Xxx-0000

Xxxxxx Xxxxxx of America

09518779

00-Xxx-0000

Xxxxxx Xxxxxx of America

60109924

24-Nov-1998

Zimbabwe

AP/P/01/02181

24-Nov-1999

ARIPO

AP/P/01/02167

24-Nov-1999

Canada

2352387

00-Xxx-0000

Xxxxxx

AP/P/01/02167

24-Nov-1999

Ghana

AP/P/01/02167

24-Nov-1999

Kenya

AP/P/01/02167

24-Nov-1999

Lesotho

AP/P/01/02167

24-Nov-1999

Malawi

AP/P/01/02167

24-Nov-1999

Patent Cooperation Treaty

US99/28080

24-Nov-1999

Patent Cooperation Treaty

IB99/01883

24-Nov-1999

Sierra Leone

AP/P/01/02167

00-Xxx-0000

Xxxxx Xxxxxx

2001/3845

24-Nov-1999

Sudan

AP/P/01/02167

00-Xxx-0000

Xxxxxxxxx

AP/P/01/02167

00-Xxx-0000

Xxxxxxxx, Xxxxxx Xxxxxxxx of

AP/P/01/02167

00-Xxx-0000

Xxxxxx

AP/P/01/02167

00-Xxx-0000

Xxxxxx Xxxxxx of America

09449042

00-Xxx-0000

Xxxxxx Xxxxxx of America

09519437

00-Xxx-0000

Xxxxxx Xxxxxx of America

60110127

27-Nov-1998

Zimbabwe

AP/P/01/02167

00-Xxx-0000

Xxxxxx Xxxxxx of America

60156093

24-Sep-1999

United Xxxxxx xx Xxxxxxx

00000000

00-Xxx-0000

Xxxxxx Xxxxxx of America

60177453

19-Jan-2000

ARIPO

AP/P/01/02285

23-Mar-2000

OAPI

OA20011000237

23-Mar-2000

Australia

2003278744

28-Aug-2003

Australia

39190/00

23-Mar-2000

Australia

2005211675

23-Sep-2005

Australia

2002244247

01-Mar-2002

Australia

2008201188

00-Xxx-0000

Xxxxxxx

00918365.8

23-Mar-2000

 

 

 
Schedule A-9
 

 

 

Belgium

00918365.8

00-Xxx-0000

Xxxxxx

XX0000000-5

23-Mar-2000

Canada

CA2496867

28-Aug-2003

Canada

2365081

23-Mar-2000

Canada

2439687

00-Xxx-0000

Xxxxxxx Xxxxxxxx of China

00805366.9

23-Mar-2000

Peoples Republic of China

0510136279.7

00-Xxx-0000

Xxxxxx, Xxxxxxxx of

00918365.8

00-Xxx-0000

Xxxxx Xxxxxxxx

XX0000-0000

00-Xxx-0000

Xxxxxxx

EP00918365.8

23-Mar-2000

EPC

03770268.5

28-Aug-2003

EPC

10181396.2

28-Aug-2003

EPC

10181424.2

28-Aug-2003

EPC

00918365.8

23-Mar-2000

EPC

04003521.4

17-Feb-2004

EPC

02709780.7

01-Mar-2002

EPC

09172321.3

06-Oct-2009

Finland

EP00918265.8

00-Xxx-0000

Xxxxxx

00918365.8

00-Xxx-0000

Xxxxxx

AP/P/01/02285

00-Xxx-0000

Xxxxxxx

US00/07883

23-Mar-2000

Ghana

AP/P/01/02285

00-Xxx-0000

Xxxxxx

2004-01776

04-May-2004

Hong Kong

02106613.2

09-Sep-2002

Hong Kong

07102606.5

09-Mar-2007

Hungary

P0140962

00-Xxx-0000

Xxxxx

1142DELNP2005

00-Xxx-0000

Xxxxx

5999DELNP2007

28-Aug-2003

India

0100796DEL

00-Xxx-0000

Xxxxx

3702DELNP2005

22-Aug-2005

India

01432/DELNP/

09-Sep-2003

Indonesia

W00200102294

23-Mar-2000

Indonesia

W-00200702183

00-Xxx-0000

Xxxxxxx

00918365.8

00-Xxx-0000

Xxxxxx

167113

24-Feb-2005

Israel

144916

00-Xxx-0000

Xxxxx

00918365.8

00-Xxx-0000

Xxxxx

2004-569763

28-Aug-2003

Japan

2000-606618

00-Xxx-0000

Xxxxx

2002-569152

29-Aug-2003

Kenya

AP/P/01/02285

23-Mar-2000

Xxxxx, Xxxxxxxx xx

0000000/0000

00-Xxx-0000

Xxxxx, Xxxxxxxx of

7012156/2001

23-Mar-2000

Xxxxx, Xxxxxxxx xx

0000000/0000

00-Xxx-0000

Xxxxx, Xxxxxxxx of

7011505/2003

01-Mar-2002

Lesotho

AP/P/01/02285

00-Xxx-0000

Xxxxxxxxxx

00918365.8

23-Mar-2000

Malawi

AP/P/01/02285

00-Xxx-0000

Xxxxxx

2001009624

23-Mar-2000

 

 

 
Schedule X-00
 

 

 

Xxxxxx

2005013921

19-Dec-2005

Monaco

00918365.8

00-Xxx-0000

Xxxxxxxxxxx

00918365.8

23-Mar-2000

New Zealand

513803

00-Xxx-0000

Xxxxxx

20014588

00-Xxx-0000

Xxxxxx

20056167

23-Dec-2005

Patent Cooperation Treaty

US03/27186

28-Aug-2003

Patent Cooperation Treaty

US00/07883

23-Mar-2000

Patent Cooperation Treaty

US02/06708

01-Mar-2002

Philippines

1200000643

00-Xxx-0000

Xxxxxxxxxxx

0-0000-000000

15-Sep-2005

Portugal

1163256

04-May-2004

Russian Federation

2001128881

23-Mar-2000

Russian Federation

2006133273

06-Sep-2006

Sierra Leone

AP/P/01/02285

23-Mar-2000

Singapore

200104916-2

00-Xxx-0000

Xxxxx Xxxxxx

2001/6980

00-Xxx-0000

Xxxxx Xxxxxx

2003/6638

00-Xxx-0000

Xxxxx

00918365.8

23-Mar-2000

Sudan

AP/P/01/02285

00-Xxx-0000

Xxxxxxxxx

AP/P/01/02285

00-Xxx-0000

Xxxxxx

00918365.8

00-Xxx-0000

Xxxxxxxxxxx

00918365.8

23-Mar-2000

Taiwan

93109651

07-Apr-2004

Taiwan

89105381

23-Mar-2000

Taiwan

93141047

09-Jun-2000

Tanzania, United Republic of

AP/P/01/02285

23-Mar-2000

Thailand

056392

22-Mar-2000

Uganda

AP/P/01/02285

00-Xxx-0000

Xxxxxx Xxxxxxx

00918365.8

00-Xxx-0000

Xxxxxx Xxxxxx of America

60398516

23-Jul-2002

United States of America

60407146

28-Aug-2002

United Xxxxxx xx Xxxxxxx

00000000

00-Xxx-0000

Xxxxxx Xxxxxx of America

10651515

28-Aug-2003

United States of America

11549580

13-Oct-2006

United Xxxxxx xx Xxxxxxx

00000000

00-Xxx-0000

Xxxxxx Xxxxxx of America

11549606

13-Oct-2006

United States of America

11549615

13-Oct-2006

United Xxxxxx xx Xxxxxxx

00000000

00-Xxx-0000

Xxxxxx Xxxxxx of America

11549875

16-Oct-2006

United Xxxxxx xx Xxxxxxx

00000000

00-Xxx-0000

Xxxxxx Xxxxxx of America

10526321

28-Feb-2005

United Xxxxxx xx Xxxxxxx

00000000

00-Xxx-0000

Xxxxxx Xxxxxx of America

11674126

12-Feb-2007

United Xxxxxx xx Xxxxxxx

00000000

00-Xxx-0000

Xxxxxx Xxxxxx of America

60550163

03-Mar-2004

United Xxxxxx xx Xxxxxxx

00000000

00-Xxx-0000

Xxxxxx Xxxxxx of America

60190140

00-Xxx-0000

Xxxxxx Xxxxxx of America

60126056

23-Mar-1999

 

 

 
Schedule X-00
 

 

 

Xxxxxx Xxxxxx xx Xxxxxxx

00000000

00-Xxx-0000

Xxxxxx Xxxxxx of America

10319356

13-Dec-2002

United Xxxxxx xx Xxxxxxx

00000000

00-Xxx-0000

Xxxxxx Xxxxxx of America

11551195

19-Oct-2006

United Xxxxxx xx Xxxxxxx

00000000

00-Xxx-0000

Xxxxxx Xxxxxx of America

12634455

09-Dec-2009

United Xxxxxx xx Xxxxxxx

00000000

00-Xxx-0000

Xxxxxx Xxxxxx of America

10602330

23-Jun-2003

United States of America

10606524

25-Jun-2003

United Xxxxxx xx Xxxxxxx

00000000

00-Xxx-0000

Xxxxxx Xxxxxx of America

10607415

25-Jun-2003

United Xxxxxx xx Xxxxxxx

00000000

00-Xxx-0000

Xxxxxx Xxxxxx of America

10876957

24-Jun-2004

United Xxxxxx xx Xxxxxxx

00000000

00-Xxx-0000

Xxxxxx Xxxxxx of America

10949694

00-Xxx-0000

Xxxxxx Xxxxxx of America

10949782

23-Sep-2004

United Xxxxxx xx Xxxxxxx

00000000

00-Xxx-0000

Xxxxxx Xxxxxx of America

10877911

24-Jun-2004

United Xxxxxx xx Xxxxxxx

00000000

00-Xxx-0000

Xxxxxx Xxxxxx of America

12571060

30-Sep-2009

United Xxxxxx xx Xxxxxxx

00000000

00-Xxx-0000

Xxxxxx Xxxxxx of America

60323016

11-Sep-2001

United Xxxxxx xx Xxxxxxx

00000000

00-Xxx-0000

Xxxxxx Xxxxxx of America

60338015

00-Xxx-0000

Xxxxxx Xxxxxx of America

60343523

20-Dec-2001

United Xxxxxx xx Xxxxxxx

00000000

00-Xxx-0000

Xxxxxx Xxxxxx of America

11696637

04-Apr-2007

United Xxxxxx xx Xxxxxxx

00000000

00-Xxx-0000

Xxxxxx Xxxxxx of America

12633721

08-Dec-2009

United Xxxxxx xx Xxxxxxx

00000000

00-Xxx-0000

Xxxxxx Xxxxxx of America

60/377570

00-Xxx-0000

Xxxxxx Xxxxxx of America

60/124087

11-Mar-1999

Viet Nam

0-0000-00000

23-Mar-2000

Zimbabwe

AP/P/01/02285

00-Xxx-0000

Xxxxxx Xxxxxx of America

09/414905

08-Oct-1999

United Xxxxxx xx Xxxxxxx

00/000000

00-Xxx-0000

Xxxxxx Xxxxxx of America

60/140028

16-Jun-1999

United Xxxxxx xx Xxxxxxx

00/000000

00-Xxx-0000

Xxxxxx Xxxxxx of America

60/254231

07-Dec-2000

United Xxxxxx xx Xxxxxxx

00/000000

00-Xxx-0000

Xxxxxx Xxxxxx of America

60/167508

01-Dec-1999

Austria

08003806.0

00-Xxx-0000

Xxxxxxx

08003806.0

28-Sep-2000

Canada

2386095

28-Sep-2000

Canada

2669753

28-Sep-2000

Canada

2670236

28-Sep-2000

Denmark

08003806.0

28-Sep-2000

EPC

00967114.0

28-Sep-2000

 

 

 
Schedule A-12
 

 

 

EPC

07012604.0

27-Jun-2007

EPC

08003806.0

29-Feb-2008

EPC

10181352.5

28-Sep-2000

Finland

08003806.0

00-Xxx-0000

Xxxxxx

08003806.0

28-Sep-2000

Germany

08003806.0

28-Sep-2000

Ireland

08003806.0

00-Xxx-0000

Xxxxx

08003806.0

28-Sep-2000

Luxembourg

08003806.0

28-Sep-2000

Monaco

08003806.0

00-Xxx-0000

Xxxxxxxxxxx

08003806.0

28-Sep-2000

Patent Cooperation Treaty

US00/26848

28-Sep-2000

Australia

200079880

23-Nov-2005

Australia

2005237117

00-Xxx-0000

Xxxxxxx

00970511.2

28-Sep-2000

Canada

2388939

28-Sep-2000

Germany

60040753.5-08

28-Sep-2000

EPC

00970511.2

28-Sep-2000

France

00970511.2

00-Xxx-0000

Xxxxxx Xxxxxxx

00970511.2

00-Xxx-0000

Xxxxx

2001533153

28-Sep-2000

Switzerland

00970511.2

28-Sep-2000

Patent Cooperation Xxxxxx

XX00/00000

00-Xxx-0000

Xxxxxx Xxxxxx of America

09675470

28-Sep-2000

Portugal

08003806.0

28-Sep-2000

Spain

08003806.0

28-Sep-2000

Sweden

08003806.0

28-Sep-2000

Switzerland

08003806.0

00-Xxx-0000

Xxxxxx Xxxxxxx

08003806.0

00-Xxx-0000

Xxxxxx Xxxxxx of America

60/157347

30-Sep-1999

United Xxxxxx xx Xxxxxxx

00000000

00-Xxx-0000

Xxxxxx Xxxxxx of America

09675323

00-Xxx-0000

Xxxxxx Xxxxxx of America

11835334

07-Aug-2007

United Xxxxxx xx Xxxxxxx

00000000

00-Xxx-0000

Xxxxxx Xxxxxx of America

11835394

07-Aug-2007

United States of America

11835397

07-Aug-2007

United Xxxxxx xx Xxxxxxx

00000000

00-Xxx-0000

Xxxxxx Xxxxxx of America

12957661

01-Dec-2010

United Xxxxxx xx Xxxxxxx

00000000

00-Xxx-0000

Xxxxxx Xxxxxx of America

60157275

00-Xxx-0000

Xxxxxx Xxxxxx of America

60236114

28-Sep-2000

United Xxxxxx xx Xxxxxxx

00000000

00-Xxx-0000

Xxxxxx Xxxxxx of America

60343452

20-Dec-2001

United States of America

60442496

22-Jan-2003

United Xxxxxx xx Xxxxxxx

00000000

00-Xxx-0000

Xxxxxx Xxxxxx of America

60257071

20-Dec-2000

Canada

2424581

09-Oct-2001

EPC

01979625.9

09-Oct-2001

Xxxxx

000000/00

00-Xxx-0000

Xxxxx

2008-327810

24-Dec-2008

 

 

 
Schedule A-13
 

 

 

Patent Cooperation Treaty

US01/31568

09-Oct-2001

United Xxxxxx xx Xxxxxxx

00000000

00-Xxx-0000

Xxxxxx Xxxxxx of America

60238659

06-Oct-2000

Canada

2522784

30-Mar-2004

EPC

04749530.4

31-Oct-2005

Patent Cooperation Treaty

US04/09739

00-Xxx-0000

Xxxxxx Xxxxxx of America

10814503

00-Xxx-0000

Xxxxxx Xxxxxx of America

11837508

11-Aug-2007

United States of America

11838154

13-Aug-2007

United Xxxxxx xx Xxxxxxx

00000000

00-Xxx-0000

Xxxxxx Xxxxxx of America

12406033

00-Xxx-0000

Xxxxxx Xxxxxx of America

12905778

15-Oct-2010

United Xxxxxx xx Xxxxxxx

00000000

00-Xxx-0000

Xxxxxx Xxxxxx of America

60459450

01-Apr-2003

Australia

2005330504

29-Sep-2005

Australia

2011200199

19-Jan-2011

Canada

2582231

29-Sep-2005

EPC

05857726.3

00-Xxx-0000

Xxxxx

1349KOLNP2007

00-Xxx-0000

Xxxxxx

182115

29-Sep-2005

Patent Cooperation Xxxxxx

XXXXX00/00000

00-Xxx-0000

Xxxxxx Xxxxxx of America

60609223

09-Sep-2004

United Xxxxxx xx Xxxxxxx

00000000

00-Xxx-0000

Xxxxxx Xxxxxx of America

11241670

29-Sep-2005

United Xxxxxx xx Xxxxxxx

00000000

00-Xxx-0000

Xxxxxx Xxxxxx of America

13030326

00-Xxx-0000

Xxxxxx Xxxxxx of America

60601835

12-Aug-2004

Canada

2590404

03-Oct-2005

Israel

182011

03-Oct-2005

Patent Cooperation Treaty

US2005/035786

03-Oct-2005

United States of America

60615307

01-Oct-2004

United Xxxxxx xx Xxxxxxx

00000000

00-Xxx-0000

Xxxxxx Xxxxxx of America

11241678

30-Sep-2005

United Xxxxxx xx Xxxxxxx

00000000

00-Xxx-0000

Xxxxxx Xxxxxx of America

11355561

00-Xxx-0000

Xxxxxx Xxxxxx of America

12968028

14-Dec-2010

United Xxxxxx xx Xxxxxxx

00000000

00-Xxx-0000

Xxxxxx Xxxxxx of America

13252846

04-Oct-2011

United States of America

60588195

14-Jul-2004

Australia

2007300404

23-Apr-2007

Australia

2010201023

17-Mar-2010

Canada

2649940

23-Apr-2007

Peoples Republic of China

2007800224496

23-Apr-2007

Eurasian Patent Organization

200802167

23-Apr-2007

EPC

07863339.3

00-Xxx-0000

Xxxxx

4253KOLNP2008

00-Xxx-0000

Xxxxxx

000000

00-Xxx-0000

Xxxxx

2009-506814

21-Oct-2008

Korea, Republic of

7028733/2008

23-Apr-2007

 

 

 
Schedule A-14
 

 

 

Patent Cooperation Treaty

US07/67235

23-Apr-2007

Singapore

200807866-9

23-Apr-2007

United Xxxxxx xx Xxxxxxx

00/000000

00-Xxx-0000

Xxxxxx Xxxxxx of America

60/825569

13-Sep-2006

United Xxxxxx xx Xxxxxxx

00/000000

00-Xxx-0000

Xxxxxx Xxxxxx of America

60/866700

00-Xxx-0000

Xxxxxx Xxxxxx of America

60/868042

00-Xxx-0000

Xxxxxx Xxxxxx of America

60/793792

22-Apr-2006

Canada

2484963

01-May-2003

EPC

03731065.3

00-Xxx-0000

Xxxxx

20040500905

01-May-2003

Patent Cooperation Treaty

US03/13477

00-Xxx-0000

Xxxxxx Xxxxxx of America

10/427280

01-May-2003

Canada

2697160

21-Aug-2008

EPC

08798419.1

21-Aug-2008

Patent Cooperation Xxxxxx

XXX/XX0000000

00-Xxx-0000

Xxxxxx Xxxxxx of America

12196271

21-Aug-2008

United Xxxxxx xx Xxxxxxx

00/000000

00-Xxx-0000

Xxxxxx Xxxxxx of America

11/941936

00-Xxx-0000

Xxxxxx Xxxxxx of America

11942689

00-Xxx-0000

Xxxxxx Xxxxxx of America

12272767

17-Nov-2008

Australia

2009212314

05-Feb-2009

Canada

2712005

00-Xxx-0000

Xxxxxxx Xxxxxxxx of China

200980104255X

05-Aug-2010

Eurasian Patent Organization

201070713/26

05-Feb-2009

EPC

09709386.8

05-Feb-2009

Hong Kong

11101901.3

25-Feb-2011

Israel

207378

03-Aug-2010

Japan

0000000000

00-Xxx-0000

Xxxxx, Xxxxxxxx of

1020107019161

05-Feb-2009

Patent Cooperation Treaty

US2009/033280

05-Feb-2009

Singapore

20105723-0

04-Aug-2010

United States of America

61093694

02-Sep-2008

United Xxxxxx xx Xxxxxxx

00000000

00-Xxx-0000

Xxxxxx Xxxxxx of America

61/026472

05-Feb-2008

Australia

2009231589

03-Apr-2009

Canada

2728889

03-Apr-2009

Peoples Republic of China

2009801121621

30-Sep-2010

EPC

09726748.8

03-Apr-2009

Hong Kong

11112286.5

00-Xxx-0000

Xxxxx

2011503236

00-Xxx-0000

Xxxxx, Xxxxxxxx of

1020107024458

03-Apr-2009

Patent Cooperation Treaty

XX0000000

03-Apr-2009

United Xxxxxx xx Xxxxxxx

00/000000

00-Xxx-0000

Xxxxxx Xxxxxx of America

61042240

03-Apr-2008

Australia

2009256009

05-Jun-2009

Canada

2724130

05-Jun-2009

Peoples Republic of China

200980119770

29-Nov-2010

EPC

09759550.8

05-Jun-2009

 

 

 
Schedule A-15
 

 

 

Hong Kong

11105425.1

00-Xxx-0000

Xxxxx

5019KOLNP2010

29-Dec-2010

Israel

209693

05-Jun-2009

Japan

2011512712

29-Nov-2010

Patent Cooperation Treaty

US0000000000

05-Jun-2009

United States of America

12479626

05-Jun-2009

United Xxxxxx xx Xxxxxxx

00000000

00-Xxx-0000

Xxxxxx Xxxxxx of America

61104083

09-Oct-2008

Patent Cooperation Treaty

US09058260

00-Xxx-0000

Xxxxxx Xxxxxx of America

61100246

25-Sep-2008

United Xxxxxx xx Xxxxxxx

00000000

00-Xxx-0000

Xxxxxx Xxxxxx of America

61184283

04-Jun-2009

United States of America

61186360

11-Jun-2009

United Xxxxxx xx Xxxxxxx

00000000

00-Xxx-0000

Xxxxxx Xxxxxx of America

61099880

24-Sep-2008

Patent Cooperation Treaty

US1165298

15-Dec-2011

United Xxxxxx xx Xxxxxxx

00000000

00-Xxx-0000

Xxxxxx Xxxxxx of America

61/262076

00-Xxx-0000

Xxxxxx Xxxxxx of America

61423457

15-Dec-2010

United States of America

61154715

23-Feb-2009

Patent Cooperation Treaty

US1165552

00-Xxx-0000

Xxxxxx Xxxxxx of America

61/262101

00-Xxx-0000

Xxxxxx Xxxxxx of America

61424173

17-Dec-2010

United States of America

13328760

16-Dec-2011

United Xxxxxx xx Xxxxxxx

00000000

00-Xxx-0000

Xxxxxx Xxxxxx of America

61261721

16-Nov-2009

Patent Cooperation Treaty

US11065482

16-Dec-2011

United States of America

13328374

16-Dec-2011

United Xxxxxx xx Xxxxxxx

00000000

00-Xxx-0000

Xxxxxx Xxxxxx of America

61424156

17-Dec-2010

Patent Cooperation Xxxxxx

XX00/00000

00-Xxx-0000

Xxxxxx Xxxxxx of America

61266092

02-Dec-2009

United States of America

61266291

03-Dec-2009

United Xxxxxx xx Xxxxxxx

00000000

00-Xxx-0000

Xxxxxx Xxxxxx of America

61266483

03-Dec-2009

United Xxxxxx xx Xxxxxxx

00000000

00-Xxx-0000

Xxxxxx Xxxxxx of America

61265294

00-Xxx-0000

Xxxxxx Xxxxxx of America

12731692

25-Mar-2010

United Xxxxxx xx Xxxxxxx

00000000

00-Xxx-0000

Xxxxxx Xxxxxx of America

61506517

11-Jul-2011

United States of America

61493267

03-Jun-2011

United Xxxxxx xx Xxxxxxx

00000000

00-Xxx-0000

Xxxxxx Xxxxxx of America

61495305

09-Jun-2011

 

 

 
Schedule A-16
 

 

 

Schedule B

 

Assigned Trademarks Registrations and Trademark Applications

 

 

Country/region

Serial No.

Filing date

United Xxxxxx xx Xxxxxxx

00000000

00-Xxx-0000

Xxxxxx Xxxxxx of America

77283286

19-Sep-2007

United Xxxxxx xx Xxxxxxx

00000000

00-Xxx-0000

Xxxxxx Xxxxxx of America

77938189

17-Feb-2010

United Xxxxxx xx Xxxxxxx

00000000

00-Xxx-0000

Xxxxxx Xxxxxx of America

77938239

00-Xxx-0000

Xxxxxx Xxxxxx xx Xxxxxxx

00000000

00-Xxx-0000

Xxxxxx Xxxxxx of America

76255928

11-May-2001

United Xxxxxx xx Xxxxxxx

00000000

00-Xxx-0000

Xxxxxx Xxxxxx of America

75799566

14-Sep-1999

United Xxxxxx xx Xxxxxxx

00000000

00-Xxx-0000

Xxxxxx Xxxxxx of America

75799567

14-Sep-1999

United Xxxxxx xx Xxxxxxx

00000000

00-Xxx-0000

Xxxxxx Xxxxxx of America

74584447

12-Oct-1994

United Xxxxxx xx Xxxxxxx

00000000

00-Xxx-0000

Xxxxxx Xxxxxx of America

75799574

21-Sep-1999

EPC

002336261

10-Aug-2001

United Xxxxxx xx Xxxxxxx

00000000

00-Xxx-0000

Xxxxxx Xxxxxx of America

76252169

09-May-2001

United Xxxxxx xx Xxxxxxx

00000000

00-Xxx-0000

Xxxxxx Xxxxxx of America

78906864

13-Jun-2006

United Xxxxxx xx Xxxxxxx

00000000

00-Xxx-0000

Xxxxxx Xxxxxx of America

78231954

00-Xxx-0000

Xxxxxx Xxxxxx of America

77283286

19-Sep-2007

United Xxxxxx xx Xxxxxxx

00000000

00-Xxx-0000

Xxxxxx Xxxxxx of America

77938189

17-Feb-2010

United Xxxxxx xx Xxxxxxx

00000000

00-Xxx-0000

Xxxxxx Xxxxxx of America

77938239

17-Feb-2010

 

 

Schedule B-1

 

 

 
 
 

 

EXHIBIT B

 

FORM OF XXXX OF SALE

 

 

 

Xxxx of Sale

 

For good and valuable consideration, the receipt and adequacy of which are hereby acknowledged, Harbor Therapeutics, Inc., a Delaware corporation ("Seller"), does hereby grant, bargain, transfer, sell, assign, convey and deliver to Reserva, LLC ("Buyer"), all of its right, title and interest in and to the Seller Materials, as such term is defined in the Asset Purchase Agreement, dated as of December 9, 2014 (the "Purchase Agreement"), by and between Seller, Harbor Diversified, Inc., a Delaware corporation, and Buyer, to have and to hold the same unto Buyer, its successors and assigns, forever.

 

Buyer acknowledges that Seller makes no representation or warranty with respect to the assets being conveyed hereby except as specifically set forth in the Purchase Agreement.

 

 

IN WITNESS WHEREOF, Seller has duly executed this Xxxx of Sale as of December 9, 2014.

 

 

 

HARBOR THERAPEUTICS, INC.

 

 

 

By: /s/Xxxxxxxxx Xxxxx

Name: Xxxxxxxxx Xxxxx

Title: Chairman

  

 
 
 

 

EXHIBIT C

 

FORM OF ASSIGNMENT AND ASSUMPTION AGREEMENT

 

 

ASSIGNMENT AND ASSUMPTION AGREEMENT

 

This Assignment and Assumption Agreement (this “Agreement”), dated as of December 9, 2014, is made by and between Harbor Therapeutics, Inc., a Delaware corporation (the “Seller”), and Reserva, LLC (the “Buyer”).

 

WHEREAS, pursuant to that certain Asset Purchase Agreement (the “Asset Purchase Agreement”), dated as of December 9, 2014, by and among the Seller, Harbor Diversified, Inc. (the “Parent”), a Delaware corporation, and Buyer, the parties have agreed to the sale by Seller and the purchase by Buyer of certain assets of Seller referred to therein as the Acquired Assets;

 

WHEREAS, in connection with the purchase and sale of the Acquired Assets, Seller has agreed to sell, convey, transfer and assign to Buyer, and Buyer has agreed to assume from Seller, the Assumed Liabilities; and

 

WHEREAS, in connection with the purchase and sale of the Acquired Assets, Seller has agreed to assign all of its rights, title and interests in, and Buyer has agreed to assume all of Seller's duties and obligations under, the Assumed Contracts.

 

NOW THEREFORE, in consideration of the foregoing premises, the parties hereby agree as follows:

 

1.     Capitalized terms used but not otherwise defined herein shall have the respective meanings ascribed thereto in the Asset Purchase Agreement.

 

2.     Subject to the terms of the Asset Purchase Agreement, Seller hereby grants, sells, conveys, transfers, sets over, delivers and assigns unto Buyer, its successors and assigns, all of Seller’s legal and equitable rights, privileges, interest and duties in and to the Assumed Liabilities.

 

3.     Subject to the terms of the Asset Purchase Agreement, Buyer hereby assumes and shall subsequently pay, discharge, and perform when due the Assumed Liabilities.

 

4.     Notwithstanding anything to the contrary contained herein, Buyer is not assuming any Excluded Liabilities and the parties agree that all such Excluded Liabilities shall remain the sole responsibility of Seller.

 

5.     Subject to the terms of the Asset Purchase Agreement, Seller hereby sells, assigns, grants, conveys and transfers to Buyer all of Seller's right, title and interest in and to the Assumed Contracts. Subject to the terms of the Asset Purchase Agreement, Buyer hereby accepts such assignment and assumes all of Seller's duties and obligations under the Assumed Contracts and agrees to pay, perform and discharge, as and when due, all of the obligations of Seller under the Assumed Contracts accruing on and after the Effective Date.

 

6.     Subject to the terms of the Asset Purchase Agreement, Seller hereby sells, assigns, grants, conveys and transfers to Buyer all of Seller's right, title and interest in and to the Seller Records. Subject to the terms of the Asset Purchase Agreement, Buyer hereby accepts such assignment.

 

7.     The terms of the Asset Purchase Agreement are incorporated herein by this reference. In the event of a conflict between the terms and conditions of this Agreement and the terms and conditions of the Asset Purchase Agreement, the terms and conditions of the Asset Purchase Agreement shall govern, supersede and prevail, and nothing in this Agreement shall be deemed to supersede, enlarge or modify any of the provisions of the Asset Purchase Agreement, all of which survive the execution and delivery of this Agreement as provided and subject to the limitations set forth in the Asset Purchase Agreement.

 

 

 
 
 

 

 

8.     All of the terms and provisions of this Agreement shall inure to the benefit of and be binding upon the parties and their respective successors and assigns, and nothing herein, express or implied, is intended to or shall confer upon any other Person, any legal or equitable right, benefit or remedy of any nature whatsoever, under or by reason of this Agreement. Any provision of this Agreement may be amended, modified or supplemented, and waivers or consents to departures from the provisions hereof may be given, only with the written agreement of Buyer and Seller.

 

9.     This Agreement shall be governed by and construed in accordance with the internal laws of the State of New York, without regard to the conflicts of law principles of such state.

 

10.     This Agreement may be executed in counterparts (including by means of facsimile or electronic delivery in portable document format), each of which shall be deemed an original, and all of which taken together shall constitute one and the same agreement.

 

 

 

[Signature Page Follows]

 

 

 
2
 

 

 

IN WITNESS WHEREOF, the parties hereto have duly executed this Assignment and Assumption Agreement as of the date first above written.

 

 

 

Harbor Therapeutics, Inc.

 

 

 

 

 

 

 

 

 

 

By:

/s/ Xxxxxxxxx Xxxxx

 

 

Name: Xxxxxxxxx Xxxxx

 

 

Title: Chairman

 

       
       
  Reserva, LLC  
       
  By:  
  Name: Xxxxxx Xxxxxx  
  Title: Chairman & Managing Member  

 

 

3

  

AutoNDA by SimpleDocs

Document Metadata

Filed: July 17th, 2017
Draft better contracts in just 5 minutes Get the weekly Law Insider newsletter packed with expert videos, webinars, ebooks, and more!